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ABSTRACT 
Background: 
Both HIV and tuberculosis (TB) have been documented to have detrimental effects on the 
nutritional status of those infected and nutritional status is a strong predictor of disease 
progression and survival. Body composition measures can be used as a proxy for nutritional 
status and takes into account body fat, muscle and water. It constitutes Fat Mass(FM), Fat 
Free Mass (FFM), Total Body Water (TBW), Extracellular Water (ECW), Intracellular water 
(ICW), Daily Energy Expenditure (DEE), Basal Metabolic Rate (BMR), phase angle and 
BMI which can be analysed as separate outcomes. Its use in evaluation of nutritional status 
has been reported to give more accurate results than the use of weight alone. We compared 
body composition measures and changes over a 12 month period in patients with HIV alone 
to patients with HIV and TB.   
Objective: 
This study aimed to determine the effect of tuberculosis co-infection on body composition in 
HIV-infected patients over the first 12 months of treatment. 
Design and Methods: 
We conducted a secondary analysis of data from the Low–Cost Monitoring of HIV in 
Resource-Limited Settings (LCM) study to investigate changes in body composition 
measures and clinical measures from antiretroviral therapy (ART) initiation between TB 
positive (TB+ve) and TB negative (TB-ve) patients. Patients had to have TB (positive smear 
and culture) at ART initiation or been diagnosed one month before or after initiation.  Body 
composition measures were at baseline, 6 months and 12 months. Continuous variables were 
compared using the Wilcoxon rank sum test and multiple regression analyses using 
longitudinal data Generalised Estimating Equation models to evaluate the relationship 
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between TB and body composition measures among HIV-infected patients, controlling for 
CD4 count, viral load, socio-economic factors and other clinical characteristics. Participants 
who provided three repeated body composition measures (baseline, 6 months and 12 months) 
were included in the multiple regression analyses. To account for the missing data, a 
sensitivity analysis was conducted using Multiple Imputation- Generalised Estimating 
Equations (MI-GEE). We analysed the data using imputed values for all missing information 
including both predictor and response variables. Multiple imputations provided complete sets 
of data by filling all missing data.  
Results: 
A total of 345 participants were evaluated at baseline. Of these, 36 (10.43%; 95%CI: 7.4%-
14.15%) participants had TB. Patients in the TB+ve and TB-ve groups were similar in 
baseline demographic characteristics. TB+ve patients had significantly lower median fat mass 
(FM) than TB-ve patients (TB+ve: 19.40kg; IQR 11.95-27.35 vs. TB-ve: 11.90kg; IQR 7.20 -
21.75; p-value=0.003) at baseline. Differences in FM by TB status at baseline were more 
pronounced in females than males. Females without TB had significantly lower FM than 
those with TB (23.60kg vs. 16.80kg) with a p-value=0.024. This difference, however, was 
not significant in males (11.95kg vs. 9.5kg). 
At baseline, TB+ve participants had a statistically significant lower median CD4 count (113 
cells/mm
3
; IQR: 63-199) than TB-ve patients (207 cells/mm
3
; IQR: 116-279), with a p-
value<0.001, TB+ve patients also had a significantly higher median log viral load (5.20; IQR: 
4.87-6.00) than TB-ve patients (5.00; IQR: 4.60-5.40) with a p-value=0.006. Although not 
statistically significant, changes in clinical and nutritional measures were larger in TB+ve 
compared to TB-ve patients. At 6 months TB+ve patients demonstrated a greater increase in 
body mass index (BMI) (1.60% vs. 2.20%; p-value=0.950) and FM (5.10% vs. 13.80%; p-
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value=0.610) than TB-ve patients. A similar trend was observed for CD4 count at 12 months 
but not for FM (19.14 vs. 42.3; p-value = 0.302). The sensitivity analysis showed similar 
results at 6 months with statistical significance, TB+ve patients demonstrated a greater 
increase in BMI (2.21% vs. 4.20%; p-value=0.044), FM (6.50% vs. 23.0%; p-value <0.001), 
and CD4 count (70% vs. 113%; p-value <0.001) compared to those without TB. 
In all GEE models; there was no association between TB and any of the body composition 
measures after adjusting for possible confounders. However, baseline CD4 count, viral load, 
education, employment and gender were all associated with body composition amongst HIV-
infected patients in both crude and adjusted models. The sensitivity analysis, however, 
showed that TB+ve patients had a decreased FM compared to TB-ve (-5.967kg; p-value = 
0.041). There were no other significant associations found.  
Conclusions  
Patients with HIV/TB co-infection have lower BMI and FM at baseline than patients with 
HIV-infection alone. This association at baseline is more apparent in females but males have 
lower nutritional measures and immunological indicators regardless of TB status. 
Malnourished status in HIV/TB infected patients has been found to be associated with 
severity of TB amongst those infected. Although we restricted the time of TB diagnosis to 
within one month of ART initiation, this analysis did not include data on treatment status, or 
severity of TB infection. This could have contributed to lack of significance for some body 
composition measures. Although not statistically significant, patients with HIV/TB co-
infection experienced greater changes in nutritional status compared to patients with HIV 
alone. Over the three visit periods, gender, education, CD4 count, viral load and employment 
were associated with body composition measures of HIV-infected patients. 
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Key Recommendations 
Integration of HIV/AIDS and TB programs is important to detect TB cases early and 
intervene. Strategies to improve outreach activities to encourage males to test often and early 
could result in earlier detection of HIV and TB which could improve overall nutritional status 
of patients. Larger changes in FM, BMI and CD4 count amongst those with TB indicates that 
treatment of TB co-infected individuals with ART and TB medication improves the 
nutritional and immunological status of such patients. Further studies should be conducted 
with information from a larger population including TB severity and TB treatment status. 
This could provide a better explanation of the relationship between TB and body composition 
measures amongst HIV-infected individuals.  
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GLOSSARY OF TERMS 
Bioelectrical Impedance: The measure of a body’s resistance to the flow of an electrical 
signal passed through the body.  
Body Cell Mass (BCM): The total mass of all the cellular elements in the body which 
constitute all the metabolically active tissue of the body 
Body Weight:  Sum of Fat mass (FM) and Fat Free Mass (FFM). This can be divided into 
three compartments i.e. Body Cell Mass, Extracellular Mass and Fat Mass.  
Body Mass Index (BMI): The level of adiposity calculated using a person’s weight and 
height. It is calculated as weight in kilograms divided by height in meters squared  
Basal Metabolic Rate (BMR): Rate of energy expenditure of a body while at rest to 
maintain vital functions.  
Daily Energy Expenditure (DEE): The number of calories a body burns at rest during an 
average day determined by the number of cells producing oxidative energy 
Dual-energy X-ray absorptiometry (DXA): An X-ray technique used to measure body 
composition, including proportion of fat and bone mineral density. 
Extracellular Mass (ECM): Tissue found outside the cell that provides the body structure 
and support and transport. 
Extracellular Water (ECW): Fluid outside the cell that circulates outside the body. ECW is 
included in extracellular mass.  
Fat Mass (FM): Functions as a major source of energy for the body. Fat stores help maintain 
body temperature and protect organs from trauma. 
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Impedance: The total resistance of a biological conductor to alternating current  
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index that is used for GEE model fit evaluation. The evaluation of choosing the best model of 
QIC and QICU is the one with the smallest value. 
Quasilikelihood under the independence model criterion (QICu): Approximation of QIC 
that can be used for variable selection. 
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CHAPTER 1: INTRODUCTION 
1.1 Background Information 
 
HIV/AIDS persists as a global pandemic with 35.3 million people globally living with HIV, 
of which 25.0 million people live in Sub-Saharan Africa(1). The relationship between 
HIV/AIDS and nutrition is well established and in both directions (2-4). The impact of 
HIV/AIDS on health and nutrition in countries greatly affected by the disease has been 
overwhelming (5). The nutritional impact is increased because HIV-related infections, like 
tuberculosis (TB), have severe implications on nutritional status that normally result in loss of 
appetite, weight loss and wasting (5, 6). This is a problem as HIV-related TB remains a 
serious challenge for the response to HIV/AIDS. In Sub-Saharan Africa, a large proportion of 
HIV-infected individuals also have TB as the occurrence of active TB in HIV-infected is 
more than eight times higher than in the HIV-uninfected (7). Of those with HIV-infection an 
estimated 30-50% will develop active TB (8) and TB is responsible for the largest number of 
deaths among those living with HIV/AIDS (1).  
South Africa has the highest number of people currently living with HIV/AIDS (6.4 million) 
in the world and TB is still one of the most common opportunistic infections in those infected 
(1). A total of 330,000 of the country’s’ estimated 520,000 new TB cases in 2011 were 
related to HIV (1). South Africa not only has the problem of the dual-epidemics of 
HIV/AIDS and TB but it also has a problem with food scarcity which leads to the problem of 
malnutrition. HIV-related illness and death has also reduced the capacity of households to 
earn an income as people may be unable to work (9). Many patients become too sick to work 
which affects their ability to afford food. The resulting poor nutrition has detrimental effects 
on their health status increasing their risk of morbidity, hospitalisation and mortality (5, 10, 
11).  Nutritional status can be measured by the use of body composition measures which is a 
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measure of the amount of fat, bone, water and muscle in the human body. The components 
that constitute body composition are Fat mass (FM), body cell mass (BCM), extracellular 
mass (ECM) and total body water (TBW).  Depletion of body weight, fat mass (FM) and fat 
free mass (FFM) are major symptoms of the advanced stages of HIV-infection. These body 
composition measures are proxies for nutrition which is a strong predictor of survival in HIV-
infected persons (12). TB on its own is associated with wasting, loss of weight and FFM, and 
is thought to be a primary cause of HIV associated wasting in co-infected individuals because 
it worsens the wasting seen in HIV-infection (13). This suggests that patterns and severity of 
nutritional deficiency in individuals with HIV/TB co-infection are likely to be different from 
those with HIV alone or TB alone. Patients with co-infection may be at great risk of extreme 
wasting and this may be a major contributing factor to increased mortality in this group of 
individuals (13, 14). 
 
Poor nutritional status has been associated with increased morbidity, mortality and poor 
immunological response to ART in HIV-infected individuals (15, 16). Malnutrition increases 
the immune suppression seen in HIV/AIDS which increases the risk of opportunistic 
infections (16) and may also interfere with a patient’s response to antiretroviral therapy 
(ART) when initiated. Opportunistic infections like TB have an effect on nutritional status 
and can affect food intake absorption and metabolism. This produces problems of infection, 
malnutrition and weakening of immune system (16) which leads to increased hospitalisations 
in HIV-infected individuals (10). This not only has implications on patients’ health but on the 
health care system as well.  
The clinical management of HIV-infected individuals should include nutritional assessment 
as good nutritional levels can help improve treatment outcomes, quality of life and overall 
health of patients (17) and poor nutrition further weakens the body’s immune system and 
accelerates disease progression (5). Interventions such as nutritional supplementation have 
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been shown to increase body weight and correct changes in FM and FFM in HIV–infected 
patients (18). The presence of TB in these patients is likely to further complicate the 
management of HIV-infected individuals as TB co-infection may increase the nutritional 
effects of HIV alone resulting in increased risk of poor response to treatment, morbidity and 
death (19). 
Nutritional status in management of patients with HIV and/or TB is assessed by routine 
measurement of body weight (5). However weight on its own provides inadequate 
information about the nutritional status of patients with HIV and/or TB and can be misleading 
(5). Kotler et al. showed that measurement of weight alone was not enough to identify losses 
of body cell mass (BCM) and FFM which studies have shown to be predictors of morbidity 
and mortality in those infected (11).  FFM has also been shown to affect treatment outcomes 
among both TB- and HIV-infected people (20) and to be a predictor of mortality in HIV-
infected individuals in other research (21).  Assessment of nutritional status through body 
composition measures like FM, FFM and BCM is therefore necessary to obtain a true 
reflection of the nutritional and health status in HIV-infected patients (8).  
 
Bioelectrical impedance analysis (BIA) is one of the tools that can be used in the 
determination of nutritional status in HIV-infected individuals and has been recommended as 
a method for measurement of body composition (22).Bioelectrical impedance is measured 
when an electrical current is passed through the body. The rate at which the electric current 
passes through the body is dependent on body composition. BIA determines the electrical 
impedance/resistance of body tissue which provides an estimate of total body water (TBW) 
(22). Specific components of weight loss that are important to the development of adverse 
outcomes like FFM, FM, BCM and other body composition measures can then be 
determined(18). This study used BIA to examine the impact of TB on body composition 
measures amongst HIV-infected patients with TB and without TB. 
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1.2 Statement of problem and Justification 
 
South Africa has the largest HIV/TB co-infection burden in the world and TB is still the 
foremost cause of death amongst HIV-infected individuals in South Africa (1). Poor 
nutritional status in people with HIV/TB co-infection is likely to be worse than in HIV or TB 
alone (23, 24). Studies have shown that poor nutritional status of patients, specifically loss of 
FM and FFM, has been associated with adverse outcomes, including hospitalisation and 
death, in both HIV-and TB-infected individuals (3, 6, 11). This has led to increasing 
recognition of the importance of nutritional assessment using body composition measures in 
HIV/AIDS management. In response to this, the South African National Guidelines on 
Nutrition recommend that total body weight, body composition, and body weight distribution 
be measured as a part of routine health care in persons with HIV (25). 
In South Africa, both TB- and HIV-infections occur among populations that already suffer 
nutritional deficiency (25). Trends of body composition in this population are likely to be 
different due to availability of nutritional food, different dietary patterns, and differences in 
HIV management practices (26). Most studies on body composition changes have been 
conducted in resource-rich places and the results from them may not be generalizable to the 
South African population (10, 27). While few studies have been conducted in other parts of 
Southern Africa (16, 28), studies on body composition in HIV and TB co-infected patients in 
South Africa are lacking. The shortage of information from the South African setting makes 
it difficult to make policy-level and individual decisions for the HIV-infected South African 
population. 
The relationship between malnutrition, TB and HIV-infection needs to be further 
investigated, especially in South Africans because of the prevalence HIV/AIDS, TB and 
malnutrition in this population (18). Studies that have been conducted on body composition 
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and HIV/TB co-infection have mostly been cross-sectional and have not measured change in 
body composition over time, especially in the era of ART (14, 16, 28, 29). The use of ART is 
associated with its own changes in body composition (5, 27) which may make body 
composition measures difficult to interpret in HIV-infected individuals on treatment. Thus, 
studies of body composition in patients on ART are important to measure response to 
treatment. 
Linkages between HIV/TB and nutrition in resource limited settings are important to improve 
outcomes of patients. This study will provide information on characteristics of patients that 
are most at need for initiatives to improve nutritional status in HIV-infected individuals. 
Limited health resources demand that interventions be targeted towards those who need them 
most and our study will provide information that will inform these decisions 
1.3 Literature Review 
This section is a narrative of the literature that was reviewed for this research. The areas 
reviewed include: HIV and malnutrition  
1.3.1 HIV and Malnutrition 
The relationship between HIV and nutrition has been studied by researchers since the 
beginning of the HIV/AIDS pandemic and poor nutritional status has been determined to 
affect HIV/AIDS and vice-versa (9). Measures of weight and BMI have been used to assess 
nutritional status in HIV management (30), however, in a study of 33 AIDS patients, Kotler 
et al. showed that HIV was associated with greater percentage losses of body composition 
measures than weight (10). Thus, they concluded that weight alone was not enough to assess 
nutritional deficiencies in HIV-infected patients and body composition measures like BCM, 
FM and FFM were important to provide a better picture of nutritional status of patients (11).  
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In another study, Kotler et al. used body composition analysis to examine the extent of tissue 
wasting in patients with AIDS defining illnesses. They observed body composition changes 
in HIV/AIDS patients similar to those in HIV-uninfected, malnourished patients (11). The 
authors suggested that loss of body cell mass (BCM) and other body composition measures 
could influence the course of the disease and suggested that preventing depletion of BCM 
could prolong survival (11). 
Likewise, Suttmann et al. showed that decreasing BCM and FFM in HIV-infected patients 
was associated with a poor prognosis (31). They showed that BCM was independently 
associated with death in HIV-infected patients and suggested detailed nutritional assessment 
as part of HIV/AIDS management. Analysis from the Tufts Nutrition for Healthy Living 
study that described weight loss and wasting in HIV disease during the time of ART showed 
that losses in weight, BCM and FM were all significant predictors of mortality in patients 
with HIV wasting syndrome (32). 
There is considerable evidence showing that there is an association between malnutrition and 
adverse clinical outcomes in people living with HIV (11, 31, 33). While the studies described 
above were conducted in resource-rich settings, this relationship has also been investigated in 
some low-resource countries. A study in Rwandan women did not show any significant 
differences in body composition in HIV-infected individuals compared to HIV-uninfected 
individuals (34).The authors suggested that this was a result of malnutrition being common in 
the cohort indicating that malnutrition was endemic in the general population (34). 
Malnutrition could be a population-level problem in resource limited settings. A study in 
Malawi investigated TB patients with and without HIV-infection. They found that both HIV-
infected and uninfected patients with TB were malnourished with no significant difference in 
their nutritional status (14). This suggested that TB may be the main cause of malnutrition not 
HIV (14). The above studies indicate that different environments may show differences in 
associations between malnutrition and HIV.  
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Patients receiving nutritional interventions have been seen to show improvements in body 
composition measures compared to those receiving placebo (18). This suggests that 
nutritional interventions could result in better treatment outcomes and reductions in morbidity 
and mortality, in HIV-infected individuals (11, 18). 
1.3.2 TB and nutritional status 
Malnourished people are more likely to develop TB and TB exacerbates malnutrition in those 
infected (6, 25). In low-resource countries where there is the highest burden of TB, the 
impact of TB on nutritional status is even bigger at population level (25). TB has been found 
in studies to be associated with serious wasting and body mass depletion, increasing the risk 
of mortality (3, 20, 35). The relationship is bidirectional and malnutrition has been shown to 
exacerbate the clinical manifestations of TB whilst TB in itself causes malnutrition (24). 
1.3.3 TB/HIV co-infection 
Studies conducted in HIV/TB co-infected patients have shown that survival rates in patients 
with HIV/TB co-infection are worse than of people with HIV alone (23, 29, 36).HIV-infected 
individuals are at greater risk of developing TB (37) and TB has been recognised as a major 
co-factor in HIV wasting (13) with some studies suggesting that TB is the main factor in the 
wasting in HIV/TB co-infected individuals (36). Co-infection of HIV and TB is thought to 
exacerbate the malnutrition seen in TB- or HIV-infection on its own (3). 
A study conducted in Singapore among TB-infected men noted that the presence of HIV co-
infection did not alter the magnitude or distribution of the body composition (FM and FFM) 
changes in patients with TB wasting (33). However, a study conducted in Malawi found that 
HIV-infection was associated with decreased FFM in patients with TB (19). Other studies 
have looked at the impact of TB on body composition measures in HIV-infected individuals. 
Paton et al. looked at the impact of TB on body composition in HIV-infected men and found 
that the nutritional status of HIV-infected men with TB was significantly worse than HIV-
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infected men without TB co-infection (6). Van Lettow et al. also found that both HIV-
infected and HIV-uninfected adults with TB were extremely malnourished compared to 
patients without TB or HIV-infection. This showed that TB is the main cause of malnutrition 
in co-infected individuals(28).Some studies have investigated gender differences in the effect 
of HIV on body composition in individuals with TB and found that the differences in body 
composition were by gender and not necessarily HIV status(38, 39). Females have been seen 
to have larger values for FM and males generally had larger values of FFM (38, 40).  
 
Confounding factors 
Some studies did not take into account the influence of confounders like socio-economic 
status and smoking and alcohol status (16, 29). It has been suggested that the setting of the 
study plays a major role in the results on the relationship between HIV, TB and malnutrition 
(26). The results from countries where malnutrition is endemic are likely to be different to 
those from countries where malnutrition is not a problem in the general population. A study 
amongst TB-infected patients in Tanzania investigated the association between gender, 
smoking and socio-economic status with body composition and found that all three were 
associated with nutritional status amongst these patients (40).  
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CONCEPTUAL FRAMEWORK 
 
  
 
 
 
 
 
 
 
 
 
 
 
FIG 1.1: Conceptual Framework. Relationship between TB, malnutrition and HIV/AIDS 
 
The conceptual framework (fig 1.1) above shows the relationship between HIV/AIDS, TB 
and nutritional status as measured by body composition measures. We created the framework 
by looking at relationships as seen in the literature (6, 29, 40). The relationship between TB 
and nutritional status is bi-directional and TB can be seen as a major co-factor in HIV-
associated wasting. Factors like socio-demographic and behavioural factors (smoking, 
employment status) may also have an effect on body composition measures and may also be 
directly associated with TB. 
1.3.4 Bioelectrical Impedance Analysis (BIA) and body composition 
 
The term body composition refers to compartments of the body that constitute person’s 
weight. Body composition may be represented as a three compartment model with FM, FFM 
Socio-demographic 
factors: Poverty, poor 
housing, economic 
deprivation  
HIV/AIDS 
Tuberculosis   
Nutritional status, body 
composition measures: 
-Fat and lean mass depletion  
-Body cell mass depletion 
-Reduced BMI 
-Decreased Weight 
 
 
 
HIV/TB Co-
infection 
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and water. It can be measured using a range of techniques that include dual-energy X-ray 
absorptiometry (DXA) and bioelectrical impedance analysis (BIA). The BIA model is 
however based on a four compartment model for body composition, FM, body cell mass 
(BCM), extracellular mass (ECM) and total body water (TBW). FFM is the sum of BCM and 
ECM, whilst TBW is the sum of extracellular water ECW and Intracellular fluid (ICF) (41). 
Phase angle is marker calculated using reactance and resistance obtained from BIA (42), BIA 
provides a better assessment of FFM and FM and has been used in epidemiological studies 
(43). 
Body mass index (BMI) 
 
BMI is used in many settings to determine nutritional status in HIV-infected individuals. It is 
a ratio between weight and height and the World Health Organization (WHO) suggests the 
following classification values: underweight (<18.5kg/m
2
), normal (18.5-24.9kg/m
2
), 
overweight (25-29.9kg/m
2
), obesity (30-39.9kg/m
2) and morbid obesity (≥ 40kg/m2) (44). As 
a measure of nutritional status it has been used as a predictor of outcomes in HIV-infected 
individuals for several years. Benova et al. investigated 1090 HIV/TB co-infected patients 
and found that patients with HIV/TB co-infection presented at baseline with lower BMI than 
patients with either TB only or HIV only (45). In addition, the authors found that remaining 
severely underweight or moving to a lower BMI increased the risk of mortality (45).  
Phase Angle  
Phase angle measures the overall wellness of an individual and is calculated from total body 
resistance and reactance (2). Lower phase angle have been found to be associated with cell 
death and lower BCM (2, 42, 46).  Improvements in phase angle have linked to 
improvements in BCM resulting in better outcomes including survival in patients with HIV 
(2, 46).A study amongst 539 HIV-infected adults in Uganda found that in Sub-Saharan 
Africa, co-infection with pulmonary TB and HIV is associated with lower phase angle (32). 
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Fat mass (FM) and fat free mass (FFM) 
Fat mass (FM) is responsible for storage of energy in the body and FFM is the combination 
of all tissues and cells that are not fat. FFM is the difference between weight and FM (46). 
The two measures have been used as measures of nutrition for prediction of survival and 
treatment outcomes. They are more accurate than methods like BMI and weight measurement 
and this makes them preferable for nutritional status measurement (43). Among HIV-infected 
patients, loss of FFM and FM has been found to be strong predictors of mortality in the ART 
era. Increases in FFM and FM have been seen with the use of ART (47) indicating improved 
nutrition in patients with the use of ART.  
1.3.5 Summary of literature review 
 
Literature is consistent on the association between HIV and nutritional status. HIV has been 
seen to be associated with depletion of body composition measures and wasting weight, 
FFM, FM and phase angle (9). The relationship between TB and nutritional status has also 
been established to be bidirectional with some researchers contending that TB is the primary 
driver of malnutrition in patients with HIV/TB co-infection (24, 23, 29). Decreases in body 
composition measures like FM, FFM and phase angle are associated with poor prognosis in 
those infected (31).  There are however gaps that exist in the knowledge base. Most studies 
evaluating the relationship between HIV/AIDS, TB and nutritional status have been cross 
sectional in nature (3, 6, 10, 11, 13).  Some studies for example, although they showed that 
the nutritional status of HIV/TB co infected patients was significantly worse than HIV alone 
(28, 29) but this study was cross sectional. There was no consideration of confounders that 
may also have an impact on nutritional status and temporality.  Cross sectional studies do not 
deal with the issue of temporality that may be in question where conditions like HIV/AIDS, 
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TB and nutrition are concerned. These studies used t-tests and nonparametric Mann-Whitney 
U-tests for comparisons between groups (3, 28, 29). Most studies conducted also looked at 
impact of TB and impact of HIV/AIDS on nutrition separately without investigating the co 
infection (10,11,26). It is important to investigate the co infection because of the burden of 
HIV/AIDS and TB in our setting. A longitudinal study where there are repeated measures 
will help solidify the knowledge base. Few studies have investigated all the factors using 
rigorous longitudinal data analysis methods. Use of more rigorous statistical methods that 
allow for adjustment for confounders and analysis of repeated measures will yield more 
reliable results (36). Although studies done prior to the era of ART provide an evidence base 
(6, 13, 31) studies that also investigate the effect of ART are important. ART on its own has 
been seen to have an impact on body composition measures (32, 37, 64) 
Setting may play an important role in this relationship however, with factors like endemic 
malnutrition in population, smoking and alcohol status, ART as well as gender playing 
important roles in these associations (40). Studies conducted in the era of ART have shown 
differences in responses of these measures to ART and more research is needed on this aspect 
(32, 37, 64). There is not enough information on the effect of TB on both body composition 
changes and body composition amongst HIV-infected individuals. This study investigated 
this effect.  
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1.4 Research Question 
Does presence of TB at ART initiation (defined as TB one month before or after ART 
initiation) in HIV-infected individuals’ have an effect on body composition? 
1.5 Research Aim 
To determine the effect of co-infection with TB on body composition among HIV-infected 
patients on HIV treatment over 12 months. 
1.6 Objectives 
1. To describe and compare baseline characteristics (including body composition 
measures) of HIV-infected adults with TB co-infection and those with HIV alone.  
2. To assess the effect  of TB on body composition changes over a period of 12 months 
in HIV-infected adults on ART. 
3. To evaluate the relationship between TB and body composition measures among 
HIV-infected adults on ART over 12 months 
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CHAPTER 2: METHODOLOGY 
 
2.0 Introduction 
This chapter describes the methods used in the study as well as procedures undertaken to 
ensure validity of the results. It details the primary study, study design, a description of the 
study population and the variables that were collected and their measurement. It also details 
the data management and analysis processes.  
2.1 Study design 
This is a secondary data analysis of prospectively collected data of HIV-infected adults 
initiating ART at the Themba Lethu Clinic in South Africa.  
2.2 Study Setting 
The primary study was conducted at the Themba Lethu HIV Clinic at Helen Joseph Hospital, 
public-sector hospital in Johannesburg, South Africa.The clinic is the largest ART site in 
South Africaand provides HIV testing services and care before ART initiation and after (48). 
It offers TB services operating a TB focal point where TB can be diagnosed and treatment 
initiated (18). 
2.3 Primary study 
The Low Cost Monitoring (LCM) of HIV in Resource-limited Settings study enrolled 353 
adult HIV-infected patients from January 2013 to May 2014 at the Helen Joseph Hospital. At 
enrolment, a baseline history, including capturing of information on demographic 
characteristics and any medications patients were currently taking was taken. Measurement of 
CD4 count, viral load, BIA and BMI was done at baseline and then every 6 months during 
the study. Total body FM, FFM, phase angle and other body composition measures were 
calculated from resistance and reactance using standard formulae. Body mass index was 
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calculated as weight in kg/ (height in meters)
 2
. Active TB was confirmed by sputum smear 
microscopy and culture. 
2.4 Study Population and Sampling 
This study analysed the records of the 353 adult, HIV-infected, ART-naïve patients. 
Participants were recruited on the day they initiated standard first-line ART under the 
2010South African National Department of Health ART treatment guidelines (49). All 
participants from the primary study who met the eligibility criteria described below were 
used in the main study. The sample size for the longitudinal data analysis was 128 patients 
and was obtained from participants with outcome data on all three visits (see Fig 3.1). 
2.4.1 Inclusion Criteria 
 HIV-infected adults (aged 18 years and older) 
 Initiating ART on day of enrolment  
2.4.2 Exclusion Criteria 
 Participants who were pregnant at enrolment or who fell pregnant during the course of 
the study  
 Participants who were already on ART or were ART-experienced at the start of the 
study 
2.5 Measurement and data sources 
 
Data for HIV-infected patients from the LCM study was analysed. Information collected 
upon initiation included patient demographics such as sex, age, employment and education as 
well clinical data such as TB co-infection status, CD4 count, BMI and viral load.  Height, 
weight and body composition measures were collected for each patient at baseline, 6 months 
and 12 months. FM, FFM, TBW, ICW, ECW, phase angle α, basal metabolic rate (BMR) and 
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daily energy expenditure (DEE) were estimated using the Rudolph J. Liedtke (RJL) Body 
Composition 2.1 software from the resistance, reactance and patient details that were 
recorded (18). 
The bioelectrical impedance of the body has been used as an indirect measure for body 
composition, because it is a reflection of both its structural and functional characteristics (41, 
52). Kyle et al. recommend BIA as the preferred method for clinical assessment of body 
composition measures, especially FM and FFM (43). When you pass an electric current 
through the body the rate at which it passes depends on body composition. The body is 
composed of components through which the electric current can flow (water with ions) and 
those that provide resistance to the flow (body fat). There is a relationship between reactance 
and the resistance of the solution (22). BIA determines the electrical impedance/resistance of 
body tissue which provides an estimate of total body water (TBW). Other body composition 
measures can then be calculated from these measures. 
2.5.1 Study measures 
2.5.1.1 Outcome variable 
Body Composition was used as a measure of nutrition in this study. There is generally no 
composite measure of the individual body composition measures and most researchers 
investigate the measures separately (6, 14, 50). We therefore analysed FM, FFM, TBW, 
ECW, ICW, DEE, BMR, phase angle, LDM and BMI as separate outcomes as some of the 
measures are correlated. The study therefore aimed to investigate the association between TB 
and each of the body composition measures separately.  
 
To determine the effect of TB on percentage change of each measure, percentage change was 
calculated by taking the difference of body composition measures at different time points and 
dividing by the initial measure. We also used height normalised indices of FM and FFM 
which are fat free mass index (FFMI) and fat mass index (FMI) as these have an advantage of 
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compensating for differences in height. We defined wasting using FFM by cut off points of 
16.7kg/m
2
for men and 14.6kg/m
2
 for women. We also defined it using FMI as <1.8kg/m
2
for 
men and <3.9kg/m
2
for women. These definitions were reported by Kyle et al. in his article on 
interpretation of body composition (51). 
 
 
2.5.1.2 Exposure Variables 
1. Main exposure 
 TB (positive smear and culture) at ART initiation, defined as TB diagnosed 
between one month before and one month after initiation. There was no 
information on TB treatment status. 
2. Socio-demographic characteristics 
 Age in years at the time of ART initiation 
 Sex 
 Level of education: (< grade 8 and ≥ grade 8) 
 Current employment status (employed and unemployed) 
 Nationality (South African and other) 
3. Clinical characteristics 
 Baseline viral load (copies/ml) 
 Baseline CD4 count (cells/mm3) 
 ART drugs initiated 
 TDF/3TC/EFV 
 TDF/3TC/NVP 
 d4T/3TC/EFV 
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2.6 Data management and analysis 
2.6.1 Data management 
The data from the primary study was stored in an excel spread sheet. Data on some routine 
information like baseline characteristics for participants was stored in an electronic patient 
management system called Therapy Edge-HIV™. This data was exported from Therapy 
Edge-HIV™ and imported into SAS. Data was then imported into STATA 12™ for analysis. 
Data from Therapy Edge-HIV™ was merged with data from the LCM study using the 
patient’s medical record ID. 
The data was cleaned and checked for duplicates and missing data. For convenience in 
analysis some variables were renamed and recoded. All variables not needed for our study 
were dropped. For the purposes of this analysis, age at initiation of ART into 10 year age 
groups (18-29.9, 30-39.9, 40-49.9, and ≥50). BMI was categorised into underweight 
(<18.5kg/m
2
), normal (18.5-24.9kg/m
2
), overweight (25-29.9kg/m
2
) and obese (≥30 kg/m2). 
For the purposes of this analysis obese and morbidly obese were analysed within the same 
category. This was done because clinically the two groups are similar and statistically this 
allowed sufficient numbers in the groups for statistical analysis. CD4 count was analysed 
both as a continuous variable and a categorical variable. The categories for CD4 count were 
<100, 100-249, 250-349 and ≥350. Viral loads were log transformed and also categorised into 
detectable (≥400 copies /ml) and undetectable (<400 copies/ml) for analysis. Government 
prescribed HIV drug regimens were used as standard drug regimens with those on Tenofovir 
(TDF) based regimen in one group and those on Stavudine (d4t) based groups in another. 
Nationality was categorised as South African or foreign and education level of patients was 
categorised into either completed grade 8 or higher or education up to grade 8.For the 
purposes of multiple imputation, data was required in wide format in order to use data from 
other visits as predictors for imputing. Generalized Estimating Equations (GEE) however 
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required being in long format. Data was converted between the two formats as analysis 
required. 
2.6.2 Exploratory Analysis 
Exploratory analysis to summarize the main characteristics of the data and to identify 
outliers, trends and data patterns was done using box plots and histograms. Normal 
probability plots, quantile–quantile plots and histograms were used to determine if continuous 
variables were normally distributed. The Shapiro-Wilk test was also used to check for 
normality of data. Non-parametric statistical tests were then performed on all of the skewed 
variables.  Exploratory analysis of data was done using the user written commands mstable 
and misschk as well as summarise in STATA to view the patterns of missingness across the 
visits. 
2.6.3 Descriptive Analysis 
As part of our descriptive analysis we looked at the missingness of data over the different 
visits. We determined the number of participants who had data for all three visits for the 
purposes of a complete case analysis. All participants enrolled into the LCM study who met 
the inclusion criteria for our analysis were used in baseline descriptive analyses regardless of 
availability of follow-up measures. Participants in the analysis were categorized as either co-
infected with TB or without TB. Baseline characteristics for each group were summarized as 
medians with interquartile ranges (IQR), as all the continuous data was skewed, and 
proportions with confidence intervals determined using binomial exact methods for 
categorical data. Continuous variables were compared using Wilcoxon rank-sum tests 
between the two groups. Stratified analysis was performed by gender to assess for effect 
measure modification because of the significant effects of gender on normal body 
composition. Box plots of body composition parameters for men, women and those with TB 
and without were plotted.  Two way comparisons of frequencies of categorical data were 
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done using Pearson’s chi squared-tests where the expected value is greater than or equal to 5 
and Fischer’s exact where the expected cell value is less than 5. A p-value of <0.05 was 
considered as significant in all analysis.  
Profile plots were used to graph the medians of the body composition parameters for the two 
groups HIV+/TB- and HIV+/TB+ over the three time points. The profiles of the groups were 
then compared to one another. 
2.6.4 Inferential Analysis 
 
2.6.4.1 Changes in body composition models by TB status (Objective 2) 
 
For selected body composition measurements, the change from baseline to each follow-up 
visit by TB status was calculated by taking the difference .To calculate percentage change the 
difference was divided by the baseline value and this was multiplied by 100. Comparisons of 
median percentage change in body composition parameters between the two groups were 
done using the Wilcoxon rank-sum test. Changes were calculated from baseline to six months 
and baseline to 12 months. All statistical tests were two sided and a p–value of less than 0.05 
was regarded as statistically significant. 
2.6.4.2 Generalised Estimating Equations (GEE)(objective 3) 
 
A subset of the study population which included only participants with body composition 
measures for all study visits was used for the models. Univariate GEE analysis was used to 
determine variables to adjust for in the multiple regression models. All variables with a 
significance level below 0.30 were included in multiple regression GEE model. Priori 
variables like age, gender and CD4 count were included in the multiple regression models 
despite lack of significance. GEE analysis was used to estimate the marginal effects of TB on 
body composition measures over time. Models were adjusted for sex, smoking status, 
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employment, level of education, baseline CD4count and viral load as determined from 
univariate analysis. 
GEE were used as these gave more robust models even when the distribution of the response 
variable is not fully identified. Investigation of the robustness of the normality assumption for 
GEE showed that it performs well with moderately skewed data (53) therefore models were 
performed under the Gaussian distribution. 
For model selection, quasi-likelihood under the independence model criterion (QIC) was used 
to select both the best working correlation and the best predictors to include in the model. In 
GEE models QICu may be taken as an approximation of QIC and is used for variable 
selection. Four types of working correlation structures were considered in model building. 
That is independent, exchangeable, autoregressive and unstructured. The QIC and QICu, 
which is an approximation to QIC, were used to select the most parsimonious model. The 
model with the lowest values of QIC and QICu was chosen.  
2.6.4.3 Sensitivity Analysis using MI-GEE (Objective 3) 
 
As part of our sensitivity analysis, we reanalysed the data using imputed values for all 
missing information including both predictor and response variables. We made the 
assumption that the missingness of the data was arbitrary and was missing completely at 
random (MAR). Multiple imputations provide complete sets of data by filling all missing 
data. Data was converted to wide format before imputation to ensure that values from the 
visits with observed data could be used to impute missing values. Transformations before 
imputation were done to provide distributions within which the imputations were to be done. 
Multiple imputations by the use of Multiple Imputation by Chained Equations (MICE) which 
uses the ICE command in STATA were conducted. Data was imputed based on the available 
Student number: 740746 
 
22 
 
data and information from other time points was used as predictors of missing values. To 
ensure reproducibility of results a seed was set. 
A total of 5 completed datasets were generated, analysed separately and then had the results 
combined using ‘Rubin’s Rules’ by using mim in STATA. After imputation, the transformed 
data was back transformed to return all values to their original scale. The distribution of the 
imputed values was compared with the corresponding distribution of the observed variables. 
Data was summarised and values generated by each imputation were looked at 
separately. Box plots and two way plots of imputed variables were plotted to see if the 
distributions after imputation made sense. Multiple imputation-generalised estimating 
equations were then used for analysis. 
For all models created using GEE, associations between body composition and TB were 
assessed and adjustments were made for smoking status, baseline CD4, viral load, sex and 
age as per the criteria described earlier. 
2.7 Ethical considerations 
The original study was reviewed and approved by the Wits Human Research Ethics 
Committee and informed consent for participation in the primary study was obtained from all 
participants. For the secondary data analysis ethical approval was also sought from the Wits 
Human Research Ethics Committee. Approval for the use of the data was sought from the 
Health Economics and Epidemiology Research Office. All exchange of data with the Health 
Economics and Epidemiology Research Office was by the use of password protected 
datasets. Data was kept in a secure computer and access was restricted to the supervisors and 
researcher only. All the data used did not have any identifying information. There was no 
information to link the data to the individuals who participated in the study.  
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CHAPTER 3: RESULTS 
3.1 Total number of participants 
 
A total of 353 participants enrolled into the LCM study were made available for this analysis. 
Of the 353 participants, 2 (0.57%) were excluded from analysis as they were pregnant, 2 
(0.57%) were excluded for not being on ART and 4 (1.15%) did not have information on the 
exposure of interest, TB, resulting in 345 patients being included in the baseline analysis. A 
total of 5 (1.41%) died during the course of the study, 39 (11.04%) were considered lost to 
follow up at either 6 months or 12 months and 20 (5.86%) were transferred out before the end 
of the study. The baseline characteristics were divided into demographic, clinical and body 
composition measures. Comparisons were made between those with TB and those without 
TB.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
353 patients in data-set  
 2 pregnant  
 2 not on ART 
 4 no information on TB 
 
 
345 patients used for baseline 
analysis  
 5 Died  
 38 Loss to follow up  
 20 Transferred out  
 157 patients missing 
data on at least one visit 
128 patients with outcome 
data on all three visits used in 
longitudinal data analysis 
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Fig 3.1: Flow chart of participants to illustrate arrival at complete case analysis cohort for longitudinal 
data analysis. Diagram shows number of participants with missing outcome data at follow up visits and the 
patients excluded for not meeting the study inclusion criteria.  
 
 
 
3.2 Baseline Characteristics of the population 
 
A total of 345 patients were analysed at baseline, of whom 36 (10.43%; 95%CI: 7.4%-
14.15%) participants were co-infected with TB at baseline. The median age at ART initiation 
was 37.59years (IQR: 31.65-43.60). More than half (63.66%; 95%CI: 58.15%-68.57%) of 
patients were female and 84.62% (95%CI: 80.59%-88.47%) of the population was South 
African, with the remainder being from other Sub-Saharan African countries. Most 
participants were employed (58.55%; 95%CI: 53.15%-68.80%) either formally or informally. 
Only 8.14% (95%CI: 5.46%-11.51 %) of the participants smoked and 91.56% (95%CI: 
88.04% -94.32%) of participants had completed at least grade 8.  
Only a small proportion of the participants were underweight (6.66%; 95%CI: 4.27%-9.83%) 
and more than 50% (95%CI: 51.11%-61.82%) had a BMI between 18.5kg/m
2
 and 
24.9kg/m
2
respectively with 14.41% (95%CI: 10.95%-18.65%) of the participants having 
BMI above 30kg/m
2
. Only 13.04% (9.67%-17.06%) had a CD4 count above 350cells/mm
3
.  
 
3.3. Baseline demographic characteristics by TB status 
 
Comparing patients with and without TB, most of the socio-demographic characteristics were 
similar between the two groups. However, those with TB were more likely to be younger 
than those without TB (p-value=0.006). Table 3.1 shows baseline demographic 
characteristics of the 345 patients stratified by TB status.  
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Table 3.1: Baseline demographic characteristics of 345 HIV-infected ART-naïve 
patients stratified by TB status 
Characteristic TB-ve (N=309) 
N(%) or Median(IQR) 
TB +ve (N=36) 
N (%) or Median(IQR) 
p-value 
Gender   
   
Male  112(36.36) 13(36.11) 0.980 
Female  196(63.64) 23(63.89) 
 
Employed  
   
No 124(40.13) 19(52.78) 0.150 
Yes  185(59.87) 17(47.22) 
 
Nationality 
   
Other  47(15.26) 5(14.29) 0.883 
South African 261(84.74) 30(85.71) 
 
Smoking 
   
No 283(91.88) 33(91.67) 0.750† 
Yes 25(8.12) 3(8.44) 
 
Education 
   
< grade 8 26(8.72) 2(5.88) 0.750 
≥ grade 8 272(91.28) 32(94.12) 
 Age at initiation in years 37.35(31.75-44.20) 35.00(31.45-38.35) 0.060ⱡ 
Age at Initiation 
   
18-24.9 55(17.86) 4(11.11) 0.006†* 
25-34.9 138(44.81) 27(75.00) 
 35-44.9 49(15.91) 3(8.33) 
 
≥45 66(21.43) 2(5.56) 
 † Fischer’s exact p-value for sparse binary variables. 
ⱡ Wilcoxon rank sum test for skewed variables  
 * Variable significant at the 5% level of significance
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3.4. Baseline clinical and body composition measures by TB status 
 
Table 3.2 describes the baseline clinical and body composition measures by TB status. Fig 
3.2 shows the baseline comparison of FM and BMI in patients with or without TB stratified 
by gender. Fig 3.3 is the graphical representation of median baseline body composition 
measures by TB status. Differences between TB+ve and TB-ve patients are not apparent 
except for BMI and FM. The box plots for FM and BMI stratified by gender show that these 
differences are more apparent in females than in males. The median BMI for TB-ve patients 
was 23.49 (IQR: 20.83-27.68) and that for TB+ve patients was 22.39 (IQR: 20.49-25.90) 
with a p-value of 0.050.  
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Table 3.2: Baseline clinical and body composition measures of patients stratified by TB 
status 
Characteristic 
TB -ve (n=309) 
N (%) or Median(IQR) 
TB +ve (n=36) 
N (%) or Median(IQR) 
p-value 
BMI group, kg/m
2
 
   
<18.5 19 (6.15) 4 (11.11) 0.091† 
18.5-24.9 172 (55.66) 23 (63.89) 
 
25-29.9 69 (22.33) 8 (22.22) 
 
≥30 49 (15.86) 1 (2.78) 
 
BMI, kg/m
2
 23.49 (20.83 - 27.68) 22.39 (20.49 - 25.90) 0.050* 
CD4  cells\mm
3
 
   
<100 70 (22.95) 13 (37.14) 0.027† 
100-249 136 (44.59) 19 (54.29) 
 
250-349 70 (22.95) 2 (5.71) 
 
≥350 29 (9.41) 1 (2.86) 
 
CD4 cells/mm
3
 207 (116.00 - 279.00) 113 (63.00 - 199.00) <0.001* 
Log viral load 5.00 (4.60 - 5.40) 5.20 (4.87 - 6.00) 0.010* 
Height, meters 1.63 (1.58 - 1.69) 1.63 (1.57 - 1.70) 0.910 
Weight, kilograms 64.00 (57.20 - 73.00) 63.80 (55.90 - 67.70) 0.160 
 
Body Composition 
 
Phase α 7.20(6.30-8.10) 7.00 (5.30-8.70) 0.280 
FM, kg 19.40 (11.95 - 27.35) 11.9(7.20 - 21.70) 0.003* 
FFM, kg 44.70 (40.60 - 49.90) 45.6 (40.40 - 52.30) 0.700 
LDM, kg 13.25 (11.70 - 14.70) 12.5 (11.30 - 14.50) 0.275 
TBW, kg 32 (28.25 - 35.80) 33.20 (28.50 - 39.80) 0.459 
ICW, kg 17.2 (15.25 - 20.75) 17.7 (15.00 - 23.00) 0.678 
ECW, kg 14.40 (12.70 - 15.90) 14.9 (13.10 - 16.70) 0.434 
BMR 1445 (1357 - 1573) 1433 (1357 - 1520) 0.506 
DEE 1940 (1782 - 2153) 1899 (1769 - 2067) 0.670 
*Variable significant at the 5% level of significance. † Fischer’s exact p-value for sparse 
binary variables. 
 
While this shows borderline statistical significance, both group medians lie in the range of 
normal BMI and therefore the difference is not clinically significant. TB+ve participants had 
a statistically significantly lower median baseline CD4 count (113cells/mm
3
IQR: 63-199) 
than TB-ve patients (207 cells/mm
3
IQR: 116.0-279.0) (p-value<0.001) and those with TB 
also had a significantly higher median baseline log viral load than those without (p-value of 
0.006). All body composition measures at baseline were not significantly different between 
the two groups at baseline except for FM.  Patients with TB had a significantly lower FM 
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(median: 11.9; IQR: 7.20- 21.70) than patients without TB (median: 19.40; IQR 11.95-27.35) 
(p-value=0.003). 
 
Table 3.3 shows a comparison of body composition measures by TB status stratified by 
gender. The differences between TB+ve patients and TB-ve patients are statistically 
significant and are more apparent in females compared to males. Comparison between TB+ve 
and TB-ve females showed statistically significant differences in BMI, CD4 count, log viral 
load and FM. These differences with the exception of log viral load were not observed in 
males.  
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Table 3.3: Comparison of clinical and body composition measures of 345 HIV-infected patients with TB and without TB by gender 
 
 
 
 
 
 
 
 
 
 
     
 
 
 
 
                    *Variable significant at the 5% level of significance. †</≥ 1.8 for males  </≥ for females. 
  
Female sex 
  
Male-sex 
 
Characteristic TB-ve TB +ve p-value TB-ve TB+ve p-value 
 
N=196 N=24 
 
N=113 N=13 
 
BMI, kg/m
2
 25.30 (22.76 - 29.43) 23.32 (20.10 - 27.47) 0.027* 21.28 (19.77 - 23.70) 21.63 (20.29 - 22.86) 0.965 
CD4 cells /mm
3
 219 (126 - 286) 71 (40 - 214) <0.001* 182 (89 - 248) 140 (103 - 173) 0.177 
Log viral load 4.90 (4.49 - 5.35) 5.16 (4.79 - 5.91) 0.036* 5.12 (4.72 - 5.45) 6.00 (5.09 - 6.42) 0.045* 
Height, meters 1.59 (1.55 - 1.63) 1.60 (1.55 - 1.63) 0.850 1.710 (1.67 - 1.75) 1.70 (1.69 - 1.76) 0.898 
Weight, kg 65.40 (57.15-75.10) 62.00 (51.30 - 69.00) 0.063 63.00 (56.70 - 69.50) 64.20 (59.90 - 66.40) 0.840 
Body Composition 
      FMI, kg/m
2
 
      <1.8 /3.9† 15 (7.81) 7 (31.82) <0.001* 49 (45.79) 9 (69.23) 0.096 
 ≥1.8/3.9† 177 (92.19) 15 (78.95) 
 
59 (54.21) 4 (30.77) 
 Phase, α 6.90 ( 6.10 - 7.80) 6.10 (5.20 - 7.50) 0.097 7.65 (6.80 - 8.70 ) 7.20 (6.60 - 8.90) 0.680 
FM, kg 23.60 (16.40 - 30.91) 16.8 (7.93 - 28.34) 0.024* 11.95 (7.52 - 19.35) 9.5 (4.95 - 13.98) 0.080 
FFM, kg 42.50 (38.70 - 45.80) 41.20 (37.63 - 45.6) 0.407 50.40 (46.60 - 56.0) 52.30 (50.40 - 56.10) 0.224 
LDM, kg 12.60 (11.40-13.60) 11.40 (11.05 - 13.34) 0.081 14.70 (13.50 - 16.05) 14.40 (12.60 - 15.70) 0.549 
TBW, kg 30.00 (27.10 - 32.80) 29.8 (25.92 - 33.20) 0.704 36.15 ( 32.95 - 40.50) 40.90 (36.01 - 41.30) 0.080 
ICW, kg 15.80 (14.40 - 17.30) 15.5 (12.9 - 17.70) 0.450 21.70 (19.40 - 24.05) 23.90 (22.57 - 24.73) 0.079 
ECW, kg 14.20 (12.50-15.72) 14.70 (12.10 - 15.41) 0.739 14.60 (13.20 - 16.60) 16.70 (14.90 - 17.12) 0.089 
BMR 1396 (1316 - 1487) 1361 (1294 - 1433) 0.197 1556 (1440 - 1648) 1520(1461 - 1590) 0.615 
DEE 1851 (17.35 - 2063) 1821 (1723 - 1950) 0.195 2081 (1925 - 2268) 2061 (1939 - 2421) 0.959 
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Fig 3.2: Baseline comparison of FM and BMI in patients with or without TB stratified by gender. There are 
statistically significant differences between those with TB and those without TB in the female gender. The same 
differences are not significant in the males. 
 
 
Fig 3.3:  Median Baseline body composition measures at baseline by TB status. Comparison of body 
composition measures between those with TB and those without at baseline shows that TB negative patients 
have a higher FM than those with TB. The differences with the other measures are not as apparent.  
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Fig 3.4: Comparison of median FM mass over the three visits between patients with TB and patients without 
TB. There is an increase in FM on visit one through to visit three in both the TB-positive and the TB-negative 
patients.  
3.5. Complete Case analysis data 
 
Only patients with outcome data for all three visits were used for complete case analysis. A 
total of 128 participants were available for the longitudinal data analysis (complete case 
analysis). Fig 3.1 shows the loss of follow up data over the one year period. We acknowledge 
that a lot of information is lost by considering only participants with outcome data for all 
three visits. A comparison of participants with missing outcome data and complete data over 
all the visits showed that there is a significant difference in gender between the two groups. 
This difference is important because gender is an important determinant of body composition. 
Table 3.4 shows a comparison of baseline characteristics between those included in complete 
case analysis (with all three visits) and those excluded (with at least one missing visit). In the 
complete case analysis group, 70.31% of participants were female whereas 59.24% of 
participants were female in the group with missing values (p-value 0.04). The percentage of 
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patients with TB is approximately 10% in both the included and excluded patients. The 
baseline demographic characteristics of those used in complete case analysis were not 
significantly different by TB co-infection as shown in Table 3.5. Baseline comparison of 
clinical and body composition measures (table 3.5) shows that TB+ve patients have 
significantly lower CD4 count (median: 85 cells/mm
3
; IQR: 61 – 15) compared to TB-ve 
patients (median: 224 cells/mm
3
; IQR: 129 – 306). TB+ve patients also had higher median 
baseline log viral load than TB-ve patients (p-value=0.043).  
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Table 3.4: Baseline comparison of participants with all three visits (included patients) and participants 
with missing values on at least one of the visits  (excluded patients) 
Baseline Characteristic  Included (N=128) Excluded (N=211) p-value 
 
N (%) or Median 
(IQR) 
N (%) or Median 
(IQR) 
 
Gender 
   Male  38 (29.69) 86 (40.76) 0.04* 
Female  90 (70.31) 125 (59.24) 
 Employed  
   No  52 (40.63) 89 (41.98) 0.806 
Yes  76 (59.38) 123 (58.02) 
 
Nationality 
   Other  19 (14.84) 33 (15.71) 0.830 
South African  109 (85.16) 177 (84.29) 
 
Smoking  
   No  109 (90.83) 165 (90.66) 0.959 
Yes  11(9.17) 17(9.34) 
 
Education 
   < grade 8 11(8.80) 15(7.43) 0.655 
≥ grade 8  114 (91.20) 187 (92.57) 
 
Age at initiation in years 36.25 (32.20 - 42.8) 37.30 (31.30 - 44.10) 0.613 
Age at initiation  
   18-24.9 18 (14.06) 40 (18.96) 0.283 
25-34.9 70 (54.69) 94 (44.55) 
 
35-44.9.9 19 (14.84) 32 (15.17) 
 
≥45 21 (16.41) 45 (21.33) 
 
Drugs 
   **TDF containing 111 (86.72) 170 (89.01) 0.537 
**d4T containing 17 (13.28) 21 (10.99) 
 
BMI kg/m
2
 23.59(21.00 - 27.65) 23.14(20.49 - 27.15) 0.396 
BMI kg/m
2
 
   <18.5 7  (5.47) 15 (7.08) 0.881 
18.5-24.9 72 (56.25) 121 (57.08) 
 
25-29.9 31 (24.22) 45 (21.23) 
 
≥ 30  18 (14.06) 31(14.62) 
 
CD4 count (cells/mm
3
) 
   <100 29 (22.66) 54 (25.47) 0.358 
100-249 54 (42.19) 101 (47.64) 
 
250-349 30 (23.44) 42 (58.33) 
 
>350 15 (11.72) 15 (7.08) 
 
Tuberculosis 
   TB –ve 114 (89.06) 191(90.09) 0.762 
TB +ve 14 (10.94) 21 (9.91) 
 
**TDF containing regimen: TDF/3TC/EFV or TDF/3TC/NVP**d4T containing regimen: d4T/3TC/EFV 
*Significant at the 5% significance level 
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Table 3.5: Baseline demographic characteristics of 128 HIV-infected ART-naïve 
patients stratified by TB status. 
Characteristic TB-ve (N=114) 
N(%) or Median(IQR) 
TB +ve (N=14) 
N (%) or Median(IQR) 
p-value 
Gender   
   
Male  34 (29.82) 4 (28.57) 0.923† 
Female  80 (78.18) 10 (71.43) 
 
Employed  
   
No 45 (39.47) 7 (50.00) 0.449 
Yes  69 (60.53) 7 (50.00) 
 
Nationality 
   
Other  18 (15.79) 1 (7.14) 0.692† 
South African 96 (84.21) 13 (92.86) 
 
Smoking 
   
No 97 (90.65) 12 (92.31) 0.661† 
Yes 10 (9.35) 1 (7.69) 
 
Education 
   
< grade 8 10 (8.93) 1 (92.31) 0.680† 
≥ grade 8 102 (91.07) 12 (92.31) 
 Age at initiation in years 36.45 (31.90 - 43.50) 35.40 (33.20 – 37.60) 0.559 
    
† Fischer’s exact p-value for sparse binary variables. 
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Table 3.6: Baseline clinical and body composition measures of 128 patients stratified by 
TB status 
Characteristic 
TB -ve (n=114) 
N (%) or Median(IQR) 
TB +ve (n=14) 
N (%) or Median(IQR) 
p-value 
BMI, kg/m
2
 23.63 (21.04 - 27.68) 23.38 (20.95 - 27.62) 0.896 
CD4 cells/mm
3
 224.00 (129.00 – 306.00) 85 (61.00 – 151.00) 0.001* 
log viral load 5.01 (4.61 – 5.445) 5.42 (5.09 – 5.97)) 0.043* 
Weight, kg 64.65 (58.20 – 71.80) 65.65 (60.00 – 69.00) 0.864 
 
Body Composition 
 
Phase α 7.10 (6.20 – 8.10) 6.3 (5.2 – 8.7) 0.289 
FM, kg 19.5 (12.30 – 28.40) 19.4 (9.90 -29.60) 0.979 
FFM, kg 44.70 (40.10 – 49.20) 41.80 (39.10 – 48.5) 0.343 
LDM, kg 13.15 (11.70 – 14.50) 11.55 (11.30 – 14.50) 0.299 
TBW, kg 32.00 (28.00 – 35.40) 30.10 (26.80 – 33.30) 0.427 
ICW, kg 17.3 (15.00 – 21.00) 15.7 (12.2 – 18.5) 0.187 
ECW, kg 14.20 (12.60 – 15.70) 14.45 (13.00 – 15.70) 0.956 
BMR 1445 (1361- 1563) 1431 (1341 - 1503) 0.556 
DEE 1952 (1800 - 2110) 1901 (1744 - 1990) 0.412 
* Significant at the 5% level of significance 
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3.5.1 Percentage change in body composition measures 
 
Changes in both clinical and body composition measures from ART initiation at baseline visit 
until 6 months as well as from initiation until 12 months were calculated and compared 
between those with TB and those without. Although some results showed particular trends, 
most were non-significant. We note that this may be as a result of the small sample size 
resulting from attrition. The small sample size decreased the precision of the estimates 
resulting in large confidence intervals.  
3.5.1.1 6 month changes (Objective 2) 
 
Table 3.5.1.1 shows a comparison of changes in body composition measures over 6 months. 
Although not statistically significant, at 6 months patients with TB demonstrated a greater 
increase in BMI (1.60% vs. 2.10%; p-value=0.950) and FM (5.10% vs. 13.80%; p-
value=0.610) than patients without TB. The difference in change in CD4 count between the 
two groups were statistically significant and patients without TB saw a smaller gain in overall 
CD4 count compared to those with TB (66.20% vs. 153.00%; p-value=0.002). Although not 
statistically significant, there was a larger increase in weight in patients with TB compared to 
those without TB (1.60% vs. 3.50%; p-value=0.879). The differences between all the changes 
in body composition measures between TB+ve patients and TB-ve patients were not 
significant. There is however a trend in the increase that suggests that TB+ve patients have 
larger increases compared to TB-ve patients.  
3.5.1.2 12 month changes (Objective 2) 
 
Table 3.5.1.2 shows a comparison of changes from baseline to 12 months. At 12 months, 
patients with TB demonstrated greater increase in FM than patients without TB (42.51% vs. 
19.14%; p-value = 0.302), although this was not statistically significant. There was also a 
greater increase in BMI amongst those with TB compared to those without TB (1.6% vs. 
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2.2%; p-value = 0.506). There is a consistent trend of greater increase in the TB+ve patients 
compared to TB-ve patients as seen at 6 months  
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Table 3.5.1.1: Comparison of changes in clinical and body composition measures between patients with TB and patients without TB from baseline to six 
months using complete data 
  TB -ve (n=114)  TB+ve (n=14) 
        Characteristic Baseline  6-months % Change** Baseline  6-months  %Change** p-value  
CD4, cells /mm
3
 224 (129.0 - 224.0) 337(235.5 - 447.0) 66.2 (25.9 - 116.6) 85.5 (61.0 - 151.0) 226.0 (121.0 - 353.0) 153.0 (79.1- 303.3) 0.016* 
BMI, kg/m
2
 23.6 (21.0 - 27.7) 23.9 (21.7 - 28.0) 1.6 (-2.0 - 5.57) 23.4 (21.0 - 27.6) 24.5 (22.2 - 24.5) 2.1 (-3.3 - 7.2) 0.950 
Weight, kg 64.7 (58.2 - 71.9) 66.0 (58.8 - 73.2) 1.6 (-1.9 - 5.7) 65.7 (60.0 - 69.0) 67.2 (59.5 -72.8) 3.5 (-3.3 - 7.2) 0.946 
FM, kg 19.5 (12.3 - 28.4) 19.4 (9.9 - 29.6 ) 5.1 (-8.0 - 25.6) 20.2 (12.5 - 28.7) 21.8 (14.4 - 29.9) 13.8 (-15.8 - 62.7) 0.610 
FFM, kg 44.7 (40.1 - 49.2) 44.8 (39.4 - 49.8) -1.0 (-6.0 - 4.3) 41.8 (39.1 - 48.5 ) 44.3 (41.6 - 46.2 ) 0.3 (-10.3 - 7.8) 0.950 
LDM, kg 13.2 ( 11.7 - 14.5) 12.7 ( 11.6-13.8) -2.94 ( -10.4 - 3.5) 12.5 (11.2 - 12.8) 12.5 (11.2 - 12.8) -2.6 (-13.9 - 6.8) 0.980 
TBW, kg 32 (28.0 - 35.4) 32.1 (28.1 - 35.5) -0.6 (-5.1 - 7.3 ) 30.1 (26.8 - 33.3) 32.5 (29.0 - 34.2) 1.8 (-4.0 - 8.9) 0.590 
ICW, kg 17.3 (15.0 - 21.0) 17.0 (14.6 - 20.0) -2.24 (-9.3 -5.5) 15.7 (12.9 - 18.5) 16.8 (15.3 - 17.6) 1.7 (-7.0-10.1) 0.438 
ECW, kg 14.2 (12.6 - 15.7) 14.6 (13.1 - 16.4) 0 (-4.0 - 8.0) 14.5 ( 13.0 - 15.7) 14.9 (13.8 -15.6) 5.8 (-3.2 - 8.5) 0.570 
Phase Angle, α  7.1 (6.2 - 8.2) 6.7 (5.9 - 7.3) -4.0 (-16.2 - 7.04) 6.3 (5.2 - 8.7) 6.3 (5.6 - 7.3) -2.0 (-21.8 - 8.5) 0.492 
BMR 1145(1361 - 1563) 1460 (1364 - 1579) 0.75 (-1.0 - 2.7) 1431 (1341 - 1503) 1466 (1339 - 1536) 1.0 (-1.4 - 2.4) 0.950 
DEE 1952 (1800 - 2110) 1921(1774 - 2094) 0 .0(-2.1 - 2.4) 1901 (1744 - 1990) 1936 (1777-2050) 1.0 (-1.4 - 2.4) 0.409 
**percent change is the ratio of the absolute increase over period divided by the baseline value ×100. The percentage change was compared between the two groups, HIV+ve/TB+ve   
and HIV+ve/TB-ve.  
 * Significant at 5% level of significance   
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Table 3.5.1.2: Comparison of changes in clinical and body composition measures between patients with TB and patients without TB from baseline to 12 
months using complete data  
  TB -ve  (n=114) TB +ve (n=14)  
Characteristic Baseline 12-months % Change**
 
Baseline 12-months % Change** p-value 
BMI(kg/m
2
 23.6 (21.0 - 27.6) 24.3 (21.9 - 29.1) 1.6 (2.0 - 5.5) 23.4 (21.0 - 27.4) 23.4 (22.4 - 30.7) 2.2 (-3.3 - 7.2) 0.506 
FM, kg 19.5 (12.30  - 28.4) 22.9 (15.8  -  32.7) 19.14 (3.8  - 45.3) 20.2 (12.5 - 28.7) 24.6 (16.2 - 36.9) 42.5(-3.2 - 109.9) 0.302 
FFM,  kg 44.7 (40.1 - 49.2) 44.75 (39.4 - 49.8) -4.1 (-7.8 - 1.5) 41.8 (39.1 - 48.5 ) 43.0 (37.0 - 44.5) -1.8 (-12.52 - 6.9) 0.760 
LDM, kg 13.2 (11.7 - 14.5) 12.8 (11.4 - 13.9) -4.8  (-9.6 - 2.8) 12.5 (11.2 - 12.8) 12.1 (11.6 - 13.0) -0.0  (-0.19  -  0.1) 0.822 
TBW, kg 32.0  (28.0-35.4) 30.5 (26.7 -35.0) -4.2 (-9.9-2.8) 30.1 (26.8 - 33.3) 30.6 (26.9 - 32.9) -0.43 (-9.8  -  4.7) 0.480 
 ICW, kg 17.3 (15.0 - 21.0) 16.2 (13.7 - 19.9) -6.8 (-13.9 - 0.45) 15.7 (12.9 - 18.5) 15.35 (13.4 - 17) -1.7 (-10.74  -  2.53) 0.370 
 ECW, kg 14.2 (12.6 - 15.7) 14.0 (12.8 - 15.5) 3.2 (-3.6 - 8.2) 14.5 (13.0 - 15.7) 14.65 (13.0 - 15.9) 1.7 (-4.19 - 5.38) 0.312 
Phase Angle, α  7.1 (6.2 - 8.2) 6.5 (5.7 - 7.1) -8.96 (-20.3 -  4.14) 6.3 (5.2 - 8.7) 6.3 (5.8 - 6.6) -0.04 (-37.6 - 16.92) 0.625 
BMR 1145.5 (1361 - 1563) 1486 (1360 - 1606) 1.38 (-0.97 -  4.3) 1431 (1341 - 1503) 1484 (1339  - 1584) 3.02 (-0.97 - 6.56) 0.288 
DEE 1952.5 (1800 - 2110) 1987 (1819 - 2.116) 0.84 (-2.94 - 4.88) 1901 (1744 - 1990) 1929.5 (1741 - 2084) 4.14 (-0.27 - 8.12) 0.124 
**percent change is the ratio of the absolute increase over period divided by the baseline value ×100. The percentage change was compared between the two groups, HIV+ve/TB+ve   
and HIV+ve/TB-ve.  
  
 
 
 
Student number: 740746 
 
40 
 
3.5.2 Profile plots and GEE models (Objective 3) 
3.5.2.1 Phase angle 
 
Fig 3.5.2.1: The above graph shows the profile plot of median phase angle from baseline visit to 12 month visit. 
Fig 3.5.2.1 shows that at baseline those with TB had a lower median phase angle than those 
without TB. Over the period under analysis, patients without TB showed a decrease in phase 
angle and those with TB seemed to maintain the same phase angle. Table 3.5.2.1 shows GEE 
analysis of phase angle. In multiple regression analysis, there is an overall decrease in 
average phase angle over follow up. Each additional visit was associated with a 0.711 
decrease in average phase angle (p-value=0.019). Being female was also associated with a 
decrease in average phase angle of 1.378 compared to being male (p-value=0.0390). The 
main exposure of interest, TB, was not associated with phase angle (p-value=0.695) at 
multivariable level but at univariate level those with TB had lower average phase angle (-
0.872; p-value=0.040). CD4 count greater than 350cells/mm
3
was associated with an 
increased average phase angle of 1.820 (p-value=0.048) compared to CD4 count less than 
100 cells/mm
3
in multivariable analysis. 
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Table3.5.2.1: GEE model for predictors of phase angle mass among 128 HIV-infected patients, 14 TB 
positive and 114 TB negative. 
  Unadjusted     Adjusted     
Characteristic Coefficient 
Confidence  
Interval p-value Coefficient 
Confidence 
Interval  p-value 
Time -0.852 -1.503 -  -0.213 0.009 -0.711 -1.306 -  -0.117 0.019* 
Tuberculosis 
      
No Reference 
     
Yes -0.872 -1.703 -  -0.041 0.040 -0.583 -1.683 - 0.522 0.659 
Log viral load -0.23 -0.977 - 0.516 0.543 -0.039 -0.735 -  0.655 0.911 
Regimen 
      
TDF Containing Reference 
     
d4T Containing -0.0866 -0.814 - 0.6411 0.815 
   
Age at initiation 
      
18-24.9 Reference 
     
25-34.9 0.164 -1.532 - 1.86 0.849 0.030 -1.655 - 1.594 0.971 
35-44.9 -0.25 -2.045 - 1.545 0.785 -0.304 -1.660 -  2.270 0.761 
≥45 -0.698 -2.435 - 1.038 0.431 -0.759 -2.114 -  0.596 0.272 
Gender 
      
Male Reference 
     Female -0.771 -1.753 - 0.212 0.124 -1.378 -2.684 -  -0729 0.039* 
Smoking 
      
No Reference 
     
Yes 1.087 -1.372 - 3.547 0.386 
   
Education 
      
<Grade 8 Reference 
     
≥Grade 8 -0.3955 2.968 - 2.177 0.763 
   
Employment 
      
Unemployed  Reference 
     
Employed  0.118 -0.774 - 1.01 0.796 
   
CD4 count  
      
<100 cells/mm3 Reference 
     
100-249 cells/mm3 0.283 0.497 - 1.063 0.477 0.161 -0.71 - 1.032 0.717 
250-349 cells/mm3 0.38 -0.479 - 1.258 0.380 0.565 -0.424 - 1.554 0.263 
≥350 cells/mm3 0.067 0.128 - 3.707 0.067 1.820 0.017 - 3.623 0.048 
 
                  TDF containing: TDF/3TC/EFV or TDF/3TC/NVP 
           d4T containing: d4T/3TC/EFV 
            *Significant at the 5% confidence interval  
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3.5.2.2 Fat mass  
 
Fig 3.5.2.2 The above graph shows the profile plot of median FM baseline visit to 12 month 
TB+ve patients showed similar FM to TB-ve patients at baseline in the profile plot for the 
complete case analysis. The rate of increase of FM appears higher in TB+ve patients 
compared to TB-ve patients by 12 month visit patients with TB+ve having higher average 
Mathis plot is suggestive of a faster gain in FM in patients with TB compared to patients 
without TB (Fig 3.5.2.2). Table 3.5.2.2 shows GEE analysis for predictors of FM. Univariate 
analysis by GEE shows that for each subsequent visit there is an increase in average FM of 
2.248kg (p-value of <0.001) and at multiple regression level the increase in average FM is 
2.231 kg (p-value = 0.001) for each subsequent visit. There is also an association between 
gender and FM. Being female was associated with increased average FM (10.989kg; p-value 
= 0.002) compared to males. Having an education beyond grade eight was associated with 
increased FM (7.675 kg; p-value= 0.001) compared to a less than grade eight education. 
There was no significant association between FM and TB at univariate level as well as 
multiple regression level (3.229 kg; p-value=0.889).
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Table 3.5.2.2: GEE model for predictors FM among 128 HIV-infected patients, 14 TB positive and 114 
TB negative. 
 
Unadjusted 
  
Adjusted 
  
Characteristics Coefficient 
Confidence 
 Interval 
p-
value Coefficient 
Confidence  
Interval p-value 
Visit  2.248 1.450 - 3.046 <0.001 2.231 1.382 - 3.080 <0.001* 
Tuberculosis 
      
No Reference 
     
Yes -0.524 -6.356 - 5.308 0.86 3.229 -4.245 - 10.703 0.889 
Regimen 
      
TDF containing  Reference 
     
d4T containing -0.776 -7.913 -  6.36 0.831 
   
Log viral  load -2.704 -5.882 - 0.475 0.096 -1.234 -3.782 - 1.181 0.980 
Age at initiation 
      
18 - 24.9 Reference 
     
25 – 34.9 0.058 -5.679 - 5.797 0.984 0768 -4.340  - 5.874 0.873 
35 – 44.9 0.918 -6.046 - 7.882 0.439 3.573 -2.895 - 10.042 0.159 
≥45 4.614 -4.250 - 13.479 0.578 4.016 -1.959 - 9.992  0.275 
Gender 
      
Males Reference 
     
Females 12.037 8.806 - 15.268 <0.001 10.989 6.722 - 15.256 0.002* 
Smoking Status 
      
No Reference 
     
Yes -4.896 -11.674 - 1.882 0.157 -0.981 -8.266 - 6.303 0.792 
Education 
      
< grade 8 Reference 
     ≥ grade 8 4.719 -0.384 - 9.822 0.070 7.675 3.033 - 12.317 0.001* 
Employment 
      
Unemployed Reference 
     
Employed -1.864 -6.028 - 2.300 0.380 
   
CD4 count 
      
< 100 cells/mm3 Reference 
     
100 - 249 cells/m3 -1.543 5.563 - 2.476 0.452 0.794 -4.770 - 3.182 0.695 
250 - 349/mm3 8.582 2.307 - 14.856 0.007 3.887 -2.05 - 9.827 0.200 
≥ 350/mm3 5.315 -0.924 - 11.556 0.095 5.828 -0.423 - 12.07 0.068 
 
TDF containing regimes: TDF/3TC/EFV or TDF/3TC/NVP 
d4T containing regimen: d4T/3TC/EFV 
* Significant at the 5% significance level 
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3.5.2.3 Body mass Index 
 
Fig 3.5.2.3: The above graph shows the profile plot of median BMI from baseline visit to 12 month visit 
The median BMI between TB+ve and TB-ve patients is similar at baseline analysis although 
TB-ve patients have a slightly higher BMI. By 6 months, there is a faster increase in median 
BMI amongst TB+ve compared to TB-ve patients. This is however followed by a slight 
decrease in BMI amongst those with TB between 6 and 12 months, leaving both groups at 
very similar median BMI’s at 12 months. Table 3.5.2.3 shows GEE analysis results for BMI. 
Those employed had 3.713kg/m
2
 increased average BMI than those not employed (p-
value=0.014). In multiple regression analysis there is an overall increase in average BMI over 
the study period. For each 6 month time period, there is an increase of 0.546kg/m
2
 in average 
BMI within the population (p-value<0.001). There was no statistically significant difference 
between those with CD4 count less than 100cells/mm
3
 and those in the 100-249 cells/mm
3
 
range however patients with CD4 count between 250-350cells/mm
3 
had 3.658kg/m
2
higher 
marginal BMI than those with CD4 count less than 100 cells/mm
3
 (p-value=0.020) and those 
with CD4 count ≥350 cells/mm3 also had a higher average marginal BMI than those in the 
20 
22 
24 
26 
28 
30 
B
M
I 
1 1.5 2 2.5 3 
Month 
TB-ve TB+ve 
Confidence Interval 
Profile plot of BMI over time 
Student number: 740746 
 
45 
 
reference CD4 count category (p-value=0.029). There was no association between TB and 
BMI after adjusting for possible confounders (1.194; p-value=0.450)Table 3.5.2.3: GEE model 
for predictors of BMI mass among 128 HIV-infected patients, 14 TB positive and 114 TB negative 
  Unadjusted      Adjusted     
Characteristic  Estimate 
Confidence 
Interval  p-Value  Estimate  
Confidence 
 Interval  p-Value 
Visit 0.547 0.367 - 0.729 <0.001 0.546  0.355 -   0.728 <0.001* 
Tuberculosis  
      
Yes Reference  
     
No -0.403 -2.9 - 2.094 0.752 1.194  -1.909 -   4.297 0.451 
Log viral load -1.072 -2.857 - 0.712 0.239 -0.537  -2.243 -  1.170 0.538 
Regime 
      
TDF containing  Reference  
     
d4T containing 0.311 -2.912 - 3.534 0.85 
   
Age at initiation   
      
 18 -24.9 Reference  
     
25-34.9 0.591 -2.282 - 3.466 0.687 0.075  -1.822 - 3.172 0.596 
35-44.9 2.264 -1.967 -  6.495 0.294 3.018  -0.851 -  6.888 0.126 
≥45 2.897 -1.637 - 7.431 0.210 2.440 -1.278 - 6.158  0.198 
Gender 
      
Males  Reference  
     
Females  5.142 3.609 - 6.675 <0.001 4.154   2.606  - 5.701 <0.001* 
Nationality 
      
Other 
      
South African  1.322 -1.156 - 3.801 0.296 0.446 -3.247 -  6.672 0.687 
Smoking Status  
      
No Reference  
     
Yes  -2.124 -5.28 - 1.034 0.87 
   
Education 
      
< Grade 8 Reference  
     
≥ Grade 8 1.637 -0.847 - 4.121 0.397 
   
Employment  
      
Unemployed Reference 
     
Employed -0.775 -2.901 - 1.352 0.185 3.713 0.739 -  6.687 0.014* 
CD4 count  
      <100 cells/mm3 Reference  
     100-249 cells/mm3 -0.465 -2.401 - 1.47 0.638 0.017 -1.956-1.991 0.986 
250-349 cells/mm3 4.378 1.300 -7.455 0.005 3.658 0.579-6.737 0.020* 
≥ 350 cells/mm3 3.811 -0.048-5.669 0.054 3.776 0.333-6.020 0.029* 
TDF based: TDF/3TC/EFV or TDF/3TC/NVP 
d4T based: d4T/3TC/EFV 
*Significant at the 5% significance level 
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3.5.2.4 Fat free mass  
 
Fig 3.5.2.4: The above graph shows the profile plot of median FFM from baseline visit to 12 
month visit. 
The profile plot depicted in figure 3.5.2.4 shows that patients with TB have a lower FFM than 
those without TB at baseline. There is however an apparent increase amongst those with TB 
which is followed by a decrease in both groups. After adjusting for other variables in the 
multiple regression model, there is a decrease in FFM of 0.728 (p-value <0.001) for each 
increase in visit number from baseline till 12 months as shown in table 3.5.2.4. Each unit 
increase in log viral load was associated with a decrease in FFM of 1.647 (p-value= 0.016). 
There was an association between age and FFM. Those between the ages of 25 – 34.9 have a 
higher FFM than those in reference age group (4.141; p-value=0.004). Those over the age of 
45 have 5.50 higher FFM than reference age group (p-value=0.003). Females have a lower 
FFM, (8.611; p-value = 0.01) than males. TB showed no significant association with FFM (-
1.587; p-value=0.267).  
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Table 3.5.2.4: GEE model for predictors of FFM among 128 HIV-infected patients, 14 TB positive 
 
  Unadjusted      Adjusted      
Characteristics Coefficient 
Confidence 
Interval p-Value Coefficient 
Confidence 
 Interval p-Value 
Visit -0.786 -1.253 - 0.319 0.001 -0.728 -1.221 - -0.237 0.004* 
Tuberculosis 
      
No Reference  
     
Yes  -1.808 -5.245 - 1.629 0.302 -1.587  -4.386 - 1.213 0.267 
Logviral load -1.291 -2.883 - 0.302 0.112 -1.647 -2.983  - -0.309 0.016* 
Regimen 
      
TDF containing Reference 
     
d4T containing 1.041 -2.605-4.688 0.576 
   
Age at initiation  
       
18 – 24.9 Reference 
     25-34.9 4.499 1.035 - 7.963 0.011 4.141  1..337 -  6.945 0.003* 
35-44.9 4.967 1.132 - 8.802 0.011 5.989  2.279 -  9.701 0.002* 
≥45 6.611 -1.692 - 14.915 0.119 5.501   1.842 -  9.168  0.003* 
Gender 
      
Male Reference 
     
Female -8.269 -10.46 - -6.078 <0.001 -8.611  -10.683 - -6.540 <0.001* 
Smoking 
      
No Reference 
     
Yes 6.341 2.490 - 10.190 0.001 -0.458   -4.157 -  3.241 0.808 
Education 
      
< grade 8 Reference  
     
≥grade 8 3.341 -0.204 - 6.886 0.065 3.2632  -0.499 -  7.025 0.089 
Employment 
      
Unemployed Reference 
     
Employed 0.663 -1.756 - 0.083 0.591 
   
CD4group 
      
<100 cells/m3 Reference 
     
100-249 cells/m3 -0.211 -3.000-2.580 0.882 -0.270 -2.56  - 2.019 0.817 
250-349 cells/mm3 0.883 2.478-4.244 0.607 1.333 -1.479 -1.14 0.353 
≥350cells/mm3 2.603 -1.919-7.125 0.259 3.161 -0.411-6.733 0.830 
 
TDF based: TDF/3TC/EFV or TDF/3TC/NVP 
d4T based:d4T/3TC/EFV 
*Significant at 5% significance level  
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3.5.2.5 Total body water  
 
Fig 3.5.2.5: The above graph shows the profile plot of median phase angle from baseline visit to visit 3 
The profile change in fig 3.5.2.5 shows no significant improvement or changes in TBW over 
the study period. In multiple regression analysis, viral load, age at initiation and gender were 
associated with total body water. There was an overall decrease in TBW over the entire study 
period. For each unit increase in visit time, there a decrease in average TBW (0.506; p-value 
0.018). An increase in log viral load was seen to be associated with a decrease in TBW (-
1.3965; p-value =0.017).There was a trend in the association between age at initiation and 
TBW as shown in table 3.5.2.5. TBW increased as the age of initiation increased. Those in 
age group have a higher TBW than those in reference age group (3.538, p-value=0.002). The 
trend continues and those in age group over 45 years of age have the highest TBW (7.474; p-
value=0.009). There was no association found between the main exposure of interest TB and 
TBW. 
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Table 3.5.2.5: GEE model for predictors of Total Body Water among 128 HIV-infected patients, 14 TB 
positive and 114 TB   negative 
  Unadjusted     Adjusted     
Characteristic Coefficient 
Confidence  
Interval p-value Coefficient 
Confidence  
Interval p-value 
Time -0.442 -0.586 - -0.028 0.036 -0.506 -0.925 - 0.087 0.018* 
Tuberculosis  
      
No Reference 
     
Yes -1.039 -3.732 - 1.654 0.449 -0.993 -3.394 - 1.408 0.225 
Log viral  load -1.013 -2.287 - 0.261 0.119 -1.396 -2.546 - -0.246 0.017* 
Regimen 
      
TDF  containing Reference 
     
d4T containing 0.9106 -1.873 -  3.694 0.521 
   
Age at initiation 
      
18-24.9 Reference 
     
25-34.9 3.984 1.374 - 6.594 0.003 3.538 1.345 - 5.731 0.002* 
35-44.9 4.604 1.733 - 7.476 0.002 4.653 2.309  - 6.997 <0..001* 
≤45  5.861 -0.580 - 12.303 0.075 7.474 1.858 - 13.091 0.009* 
Gender 
      
Male Reference  
     
Female -6.016 -7.764 - -4.269 <0.001 -6.061 -8.032 - -4.091 <0.001* 
Nationality 
      
Other Reference  
     
South African -1.274 -3.724 - 1.176 0.308 
   
Smoking 
      
No Reference 
     
Yes 4.591 1.414 - 7.768 0.005 -0.581 -3.519 - 2.357 0.698 
Education 
      
<Grade 8 Reference  
     
≥Grade 8 2.36 -0.539 - 5.26 0.111 2.551 -0.712 - 5.814 0.125 
Employed 
      
No Reference 
     
Yes 0.314 -1.593 - 2.221 0.747 
   
CD4count  
      
<100 cells/mm3 Reference 
     
100-249 cells/mm3 -0.211 -3.000 -2.580 0.882 0.256 -1.589-2.095 0.788 
250-34cells/mm3 0.607 -2.478-4.244 0.607 0.303 -1.156 - 3.722 0.303 
≥ 350 cells/mm3 0.259 -1.919-7.125 0.259 1.768 -1.259- 4.795 0.252 
*TDF based: TDF/3TC/EFV or TDF/3TC/NVP 
*d4T based:d4T/3TC/EFV 
* Significant at 5% significance level  
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3.6 Sensitivity Analysis 
 
Due to substantial amounts of missing data over the follow up period, we conducted a 
complete case analysis of participants with outcome data for all three visits. We however also 
reanalysed our data after using multiple imputations to fill missing values for both predictors 
and outcome variables as part of our sensitivity analysis. Multiple imputations provide 
complete sets of data by filling all missing data.  Below are the results our sensitivity 
analysis.  
3.6.1 Changes in body composition 
3.6.1.1 6 months  
 
Table 3.6.1.1 shows comparison in measures after multiple imputations. Change in both 
clinical and body composition measures from ART initiation until 6 months were calculated 
and compared between those with TB and those without. At 6 months, patients with TB 
demonstrated a greater increase in BMI (2.21% vs. 4.20%; p-value=0.044), FM (6.50% vs. 
23.0%; p-value <0.001), and CD4 count (70% vs. 113%; p-value <0.001) compared to those 
without TB. Patients without TB, however, had an increase in FFM (0.85%) vs. a decrease of 
4.6% (p=0.007) for patients with TB. The same trend was observed with TBW as those 
without TB showed no change whilst those with TB showed a decrease of 1.95% (p=0.002).  
3.6.1.2 12 months 
At 12 months patients with TB demonstrated greater increase in FM (53.84% vs. 23.58%; 
p=0.000), BMR (1.68% vs. 3.98%; p-value <0.001 and DEE (1.54% vs. 3.98%; p=0.048) 
compared to those without TB. ECW in those with TB did not change whilst in those without 
TB there was a decrease – of 1.53% (p-value=0.047) (Table 3.6.1.2) 
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3.6.2 Generalized estimating equations 
 
Table 3.6.2.1 shows GEE analysis of FM, FFM and BMI at multiple regression level. For 
each subsequent visit there is an increase in FM of 2.414kg (p-value of <0.001).There is also 
an association between gender and FM. Being female was associated with increased average 
FM (7.130kg; p value <0.001) compared to males. Having an education beyond grade eight 
was associated with increased FM (6.632 kg; p-value= 0.003) compared to a less than grade 
eight education. There was an association between age at initiation and FM. As age at 
initiation increases, there is an increase in FM. There was an association between TB and 
FM. Those with TB had a decreased FM compared to those without TB (-5.967; p-value = 
0.041). 
 
GEE analysis of BMI shows that those employed had 3.256kg/m
2
 increased average BMI 
than those not employed (p-value=0.001). There was an overall increase in average BMI over 
the study period. For each 6 month time period, there is an increase of 0.543kg/m
2
 in average 
BMI within the population (p-value=0.010). Gender was associated with BMI and as age at 
initiation increases, there is an increase in BMI. Analysis of FFM shows a decrease of FFM 
over the 12 months follow up period. It also shows an increase in average FFM as age at 
initiation increases. Females have a lower average FFM than males. Table 3.6.2.2 shows 
there was a decrease in average TBW over time and an increase in TBW as age at initiation 
increases. Being female is associated with an increased average TBW.  
 
There are some differences in results obtained from the complete case analysis and the 
sensitivity analysis.  The main difference is that FM was found to be significantly less in 
TB+ve individuals compared to TB-ve in GEE analysis (-5.967kg;p-value=0.041). For the 
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sensitivity analysis, age at initiation becomes a significant factor associated with body 
composition measures in multiple regression analysis.  Gender and education are significantly 
associated with body composition measures in both analyses.  
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Table 3.6.1.1: Comparison of changes in clinical and body composition measures between patients with TB and patients without TB from baseline to six 
months 
  TB Negative  TB Positive    
Characteristic Baseline 6 months %change** Baseline 6 months % change** 
p-
value 
BMI, kg/m
2
 23.5 (20.8 -27.7) 24(21.9 -28.0) 2.2 (-2.80-8.07) 22.50(20.2 -25.9) 23.8 (21.5 - 27.3)  4.2 (-2.8 - 10.7) 0.044* 
FM, kg 19.1(11.5-27.1)  21.1(13.6-29.47) 6.50(-12.0 -40.0) 14.0(7.90-21.80) 19.6(13.0 -26.6) 23.0(10.8-118.7) 0.000* 
CD4, cells/mm
3
 207(116.0-279.0) 318(203-453) 70(22.9- 145.7) 113 (63-199) 227(133.8 – 353.0) 113(57.0 - 246.2) 0.000* 
Weight, kg 64.00 (57.2 -73.00) 65.9 (59.7 -74.10) 1.90(2.7 -8.0) 63.80(55.9-67.7) 64.7(59.0 -70.9) 4.00(-3.3 -10.7) 0.892 
Phase angle, α 7.19(6.3 -8.09) 6.79(5.7 -7.9) -3.50 (-2.5 -15.4) 6.99 (5.5 -8.2) 6.49(5.3 -8.2) 0.17(-23.5-24.5) 0.114 
FFM, kg 44.7 (40.8 -50.0) 44.8 (40.1 -49.6) 0.8  (-8.6-8.7) 45.6 (40.38 – 49.8) 44.1 (39.9 -47.9) -4.60 (-14.2-7.70) 0.007* 
LDM, kg 13.33(1.7-14.7) 12.8(11.30-14.70) -1.16(-14.4-10.94) 12.5(11.15-14.40) 12.50(11.0-14.90) -0.88(-14.60-15.76) 0.471 
TBW, kg 32.0 (28.3 -35.9) 31.9 (28.3 -36.0) 0(-9.4 -11.5) 33.2(29.1 -39.8) 31.3(28.6 -34.2) -1.95(-15.7-7.70) 0.002* 
ICW, kg 17.20 (15.3-20.9) 17.17(14.9-19.9) -1.7(-12.5-9.2) 16.80(15.00-22.80) 16.84(1530-19.48) -1.70(-12.50-9.20) 0.168 
ECW, kg 14.4 (12.7 -15.8) 14.7  (12.9 -16.3) 0.8 (-6.4-10.9) 14.9 (13.3 -16.7) 14.6 (12.9 -15.6) 0.6 (-12.3 -9.1) 0.205 
BMR 1443(1357-1572) 1466(1352-1613) 0.81(2.1 -4.6) 1431(1341-1506) 1452(1339-1582) 2.3(-1.5 -6.2) 0.062 
DEE 1938(1782-2151) 1943(1755-2183) 0.27(-6.30-6.00) 1886(1764-2061) 1886(1764-2061) 1.89(-2.2 -6.10) 0.120 
 **percent change is the ratio of the absolute increase over period divided by the baseline value ×100. The percentage change was compared between the two 
groups, HIV+ve/TB+ve   and HIV+ve/TB-ve. 
                 *Significant at 5% confidence level  
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Table 3.6.1.2: Comparison of changes in clinical and body composition measures between patients with TB and patients without TB from baseline to 
12 months 
 **percent change is the ratio of the absolute increase over period divided by the baseline value ×100. The percentage change was compared between the two groups, 
HIV+ve/TB+ve   and HIV+ve/TB-ve.  
*Significant at 5% significance level  
 
 
 
 
 
  TB Negative  TB Positive    
Characteristic Baseline 12 months  %change Baseline  12  months  % change p-value 
BMI, kg/m
2
 23.6 (20.8 - 27.6) 24.5 (21.9 – 29.1) 4.37(-1.1 -9.7) 22.4 (20.3 – 25.4) 24.9 (22.4 – 30.2) 9.4 (1.5 – 18.5) 0.139 
FM, kg 19.1 (11.5 - 27.1)  23.60 (15.80 - 33.38) 20.3 (1.0 - 64.2) 14.0 (7.9 - 21.8) 23.8 (16.2 - 34.7) 53.8 (9.8 - 156.9) 0.000* 
Phase, α 7.2 (6.3 - 8.1) 6.5 (5.5 - 7.6) -9.5 (-25.8 - 10.9) 7.0(5.5 - 8.2) 6.4 (5.6 - 7.3) -7.5 (-32.9 - 16.9) 0.776 
FFM, kg 44.7 (40.8 -50.0) 44.9 (40.0 - 50.0) -4.5 (-8.6 -0.8) 45.6 (40.4 - 49.8) 42.8 (38.7-44.5) -3.2 (-12.5 -3.13) 0.326 
LDM, kg 13.33(1.7-14.7) 12.8(11.40-14.10  ) -4.4 (-9.15-3.05) 12.5(11.2 -14.4) 12.1(11.6-12.8) 2.65(-15.9 -8.8) 0.480 
TBW, kg 32.0 (28.3 -35.90 30.8(26.7 -35.20 -4.7 (-10.2 -2.6) 33.2 (29.1 -39.8) 30.0(26.9-32.3) -1.20(-9.8 -2.3) 0.112 
ICW, kg 17.2(15.3-20.9) 16.4(13.8-19.9) -6.9 (-14.28-0.00) 16.8 (15.0 -22.8) 15.1(13.4-17.0) -6.2 (-10.7 -2.4) 0.140 
ECW, kg 14.4 (12.7 - 15.8) 14.20(12.80-15.70) -1.53(-7.5 -3.9) 14.9 (13.3 -16.7) 13.7 (13.0 -15.5) 0.0 (8.2 -9.9) 0.047* 
BMR 1443(1357-1572) 1479(1356-1606) 1.7  (-1.02-4.26) 1431(1341-1506) 1486(1339-1565) 4.0 (-1.0 -8.2) 0.000* 
DEE 1938(1782-2151) 1988(1809-2147) 1.5(-2.16-5.57) 1886(1764-2061) 1932(1741-2034) 3.98(-0.98-8.12) 0.048* 
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Table 3.6.2.1: Predictors of FM, body mass index and FFM among 340 HIV-infected patients, 34 TB infected patients and 306 TB uninfected patients. 
 
Regression coefficients with their corresponding 95% confidence intervals  and P-values for  
 
 
FM(kg)  BMI (kg/m
2
) FFM(kg)  
 
Coefficient  Confidence interval P-value  Coefficient  
Confidence 
interval P-value  Coefficient  Confidence interval  P-value  
Visit 2.414  1.527 - 3.300  0.000* 0.543  0.156 -0.929  0.010* -0.250  -1.459 - -0.460 <0.001* 
logviral -0.936  -2.850 -  0.977   0.334 -0.272 -1.146 - 0.603  0.542 0.422 -1.682 - -0.024 0.045* 
Age at initiation  
         18-24.9 Reference  
        25-34.9 2.887  -0.123 - 5.897   0.060 1.403  -0.280 -3.086  0.100 0.875  0.472 - 3.950  0.013* 
35-44.9 5.625   2.128 -  9.121   0.002* 3.143  1.183 -  5.102  0.002* 1.009  1.106 - 5.125 0.003* 
≥45 7.342 1.563 - 13.121  0.013* 3.789 0.988 - 6.590 0.009* 1.659   0.155 -  6.699 0.040* 
Gender 
         Male Reference  
        Female 7.130  3.618 - 10.643 <0.001* 4.335  2.775 - 5.892 0.000* -0.743  -7.840 - -4.880   <0.001* 
Education 
         <grade 8 Reference  
        ≥ grade 8 6.632 2.320 - 10.944  0.003* 
      Employment 
         Unemployed Reference  
        Employed -0.221 -2.652 -  2.210   0.858 3.256   1.388 - 5.123 0.001 0.638  -1.196 -  1.330    0.917 
Tuberculosis  
         No Reference  
        Yes -5.967  -11.673 - -0.261  0.041* -0.232 -1.934 - 1.468 0.787 0.984  -2.311 - 1.675  0.748 
CD4 
         <100 cells/mm
3
 Reference 
        100-250 cells/mm
3
 0.516 -2.375 - 3.407 0.725 0.391  -1.008 - 1.789 0.582 0.625  -1.039 -  2.290  0.45 
250-349 cells/mm
3
 2.351 -1.575 - 6.277 0.240 1.082   -0.718 - 2.883 0.239 0.983  -0.250 -  3.633  0.087 
≥350 cells/mm3 0.337 -0.595 - 4.473 0.883 0.742  -1.585 -  3.069 0.531 1.291  -0.594 -  4.473  0.133 
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Table 3.6.2.2: Predictors of Phase angle and total body water for 340 HIV-infected patients, 34 TB infected and 306 TB uninfected patients 
 
 
 
 
 
 
 
 
 
 
 
 
                              *Significance at the 5% level of significance 
 
GEE coefficients with their corresponding 95% confidence intervals and P-values for  
 
Phase angle, α Total body water, kg 
 
Coefficient 
Confidence 
interval P-value Coefficient 
Confidence 
interval P-value 
time -0.317 -1.166 -  0.533 0.429 -0.652 -1.019 - 0.284 0.001* 
Logviral load -0.085 -0.728  - 0.559 0.793 -0.669 -1.387 -0 .049 0.068 
Age at initiation  
      18-24.9 Reference 
     25-34.9 0.056 -1.855 -  1.967 0.953 1.685 0.343 - 3.369 0.017* 
35-44..9 -0.333 -2.251 -  1.585 0.720 2.629 1.196 -  4.668 0.001* 
 ≥45 -0.557 -2.688 -1.573 0.593 2.718 0.462 - 5.909 0.022* 
Gender 
      Male Reference 
     Female -0.199 -1.386 -  0.988 0.731 -4.762 -5.896  - 3.627 <0.001* 
Nationality 
   
-0.443 -1.625 - 0.739 0.462 
Other Reference  
     South African  
   
-0.471 -1.674 -  0.733644 0.443 
Tuberculosis  
      No Reference  
     Yes  -0.168 -1.585 -   1.249 0.805 -0.182 -1.711 - 1.348 0.812 
CD4 
      <100 cells/mm
2
 Reference 
     100-250 cells/mm
2
 0.031 -0.825 - 0.886 0.943 0.841 -0.518 - 2.199 0.217 
250-349 cells/mm
2
 0.167 -1.163 -  1.497 0.791 1.366 -0.380 - 3.111 0.122 
≥350 cells/mm2 1.444 -2.212 -  5.099 0.420 1.112 -1.345 - 3.569 0.370 
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3.7. Comparison of Complete case analysis and imputed results 
 
Although there are some similarities in the results found using complete case analysis and imputed 
values, there are some differences as well. For this reason we discuss the results obtained from the 
complete case analysis.  
Fat Mass (FM) 
 
Both GEE models for fat mass show that for there was a significant increase in average FM over the 
study period. They also show that females have a higher average FM than males and those with an 
education beyond grade eight had higher average FM than their less educated counterparts.  Results 
from multiple imputation show that those with TB had significantly lower FM than patients without 
TB whilst there is no significant association between TB and FM. The only other difference is that 
age at initiation is significantly associated with FM in GEE models that use imputed data.  
Body mass index (BMI) 
 
In both complete case analysis and imputed data analysis, time, gender and employment are 
significantly associated with BMI. The coefficients and the significance levels are similar in both 
analyses. The one difference in results is that age at initiation is significantly associated with BMI 
when analysis is done using imputed data.  
Fat free mass (FFM) 
 
The analyses using complete case analysis and multiple imputation yielded similar results. There was 
a significant increase in FFM over the study period in both analyses. Log viral load and gender were 
both significantly associated with FFM. Age at initiation was found to be associated with FM in 
imputed data analysis but not in complete case analysis. 
Phase angle  
 
There were significant differences in models using complete case analysis and using multiple 
imputation. None of the variables were significant in the multiple imputation variables. The complete 
case analysis showed that there was a decrease in phase angle over time and being female was 
associated with a reduced phase angle.  
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CHAPTER 4: DISCUSSION 
4.0 Introduction 
 
This chapter is an overview of the study’s findings for each outcome. We go on to discuss all 
the factors associated with each outcome, starting with the main exposure of the study which 
is TB. Relationships between the findings in our study compared to findings from other 
studies are explored and possible reasons for our findings are also discussed. The chapter also 
gives an overview of the relevance of the findings with regards to HIV, TB and nutrition and 
also highlights the limitations of the study. We also discuss potential areas of study to be 
pursued beyond this study.  
4.1 Summary of results 
 
 At baseline patients with TB/HIV co-infection appeared with lower indicators of nutrition. 
They presented with lower FM, BMI, CD4 count and higher viral load than TB –ve patients. 
After stratification by gender the differences in measures between TB+ve and TB-ve patients 
were found to be significant in females but not in males as females with TB showed 
significantly lower FM, FMI and BMI. They also had lower CD4 counts and higher viral load 
than TB-ve females. There were no significant differences between TB-ve males and TB+ve 
males. Results of complete case analysis showed that TB+ve patients had greater increases in 
CD4 count, FM, weight, BMI and FFM although not statistically significant. The rest could 
have a clinical bearing so were noted. These results were consistent throughout study period.  
GEE analysis showed no significant associations between TB and body composition measure. 
The analysis however showed significant associations between selected body composition 
measures and gender, education, employment, CD4 count and viral load. All patients enrolled 
in the study had been initiated on a first line ART regimen. The regimen of ART the 
participants were on showed no association with any of the body composition measures. A 
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study by Shlay et al on Long term body composition changes in ART showed Changes in 
total and regional body but the changes did not differ by ART regimen (38). The fact that all 
the patients in our study (Both HIV only and HIV/TB co-infected) were on ART and that 
only first line regime effect was investigated could influence our results. It could have 
resulted in our failure to see a significant difference in body composition as ART has its own 
effects which are to be further investigated.   
Sensitivity analysis conducted multiple imputation showed similar associations as complete 
case analysis with the exception of age which showed associations with the different 
measures in the sensitivity analysis. The results also showed greater increases in FM and 
BMI in TB+ve than in TB-ve patient. Contrary to results from complete case analysis, FFM 
changes were significantly greater in TB-ve patients compared to TB+ve patients. The results 
of complete case analysis take precedence over results from imputed data. GEE analysis with 
imputed data showed a significant association between TB and FM, TB+ve patients have 
lower average FM than TB-ve patients with HIV.  
4.2 Body composition and clinical measures 
 
Our analysis showed that at baseline patients with HIV/TB co-infection had lower CD4 count 
compared to patients with HIV alone. Several other studies have concluded the same (54, 55). 
The results highlight the relationship between immunological failure and TB. Patients with 
TB have a compromised immunological status and patients with a compromised immune 
system are more likely to get TB. At baseline no temporality can be established. HIV/AIDS 
and TB combined have a negative impact on immunological status as measured by CD4 
count. Females had a higher baseline CD4 count at baseline compared to males. This is in 
line with studies that have shown that male gender is associated with late presentation for 
treatment in HIV (56). This information is important when making interventions for early 
HIV counselling and testing. 
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In this analysis, we compared the change in CD4 count and body composition measures 
between patients with HIV alone and patients with HIV/TB co-infection. There was a greater 
increase of these measures in patients with HIV/TB co-infection from baseline to 6 months. 
This was consistent with results from a study that compared CD4 count recovery in HIV-
infected/TB+ve and HIV-infected/TB-ve. Wanchu et al showed patients with co-infection 
had significantly greater increase in CD4 count compared to those with HIV alone (57). 
Patients with HIV/TB co-infection start out with significantly lower CD4 count but treatment 
with ART as well as anti TB treatment has a positive impact on CD4 count and the change is 
marked in these patients. 
Our baseline analysis of body composition measures by TB status showed that TB+ve 
patients had a lower FM and BMI compared to individuals without TB when presenting for 
treatment. This is consistent with studies that have shown that HIV/TB co-infection results in 
lower body composition measures (3, 6, 13). The effect of TB in HIV-infected individuals is 
to further reduce nutritional status. Our results are also consistent with results from the study 
by Paton and Ng (29) which showed that TB is associated to lower FFM and FM than 
patients without TB. The authors measured body composition between in 18 patients with TB 
and 22 without TB. This study was however not conducted amongst HIV-infected patients 
only. In another study however they looked at the impact of TB on body composition of HIV- 
infected men in Brazil in a cross-sectional study. They found that nutritional status of those 
with co-infection was generally worse than those with HIV alone. They found that HIV/TB 
co-infected patients had a significantly lower mean BCM. Another finding was that FM and 
FFM showed small but insignificant reductions. The authors concluded that FM and FFM 
underestimated the nutritional deficit (6). A study among 944 patients with HIV, TB or 
HIV/TB co-infection in Uganda, it was shown that patients with TB co-infection had a lower 
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FM than their counter-parts with HIV-infection only (58). This was also in another study that 
showed that reduced FM and FFM was seen when patients present with TB (19). 
It has been shown that TB may result in greater FM in females but lower FFM in males (36). 
We stratified our baseline analysis by gender and our analysis showed an association between 
TB and FM was in females but not in males. Females with HIV/TB co-infection showed 
significantly lower FM than females with HIV alone. This difference was not evident in 
males. The lack of difference in both FM and FFM amongst TB+ve and TB-ve males could 
be because patients in this group are more homogenous with regards to HIV-infection as 
measured by CD4 count. Males at baseline were generally worse off than females, with lower 
CD4 count and higher viral load but the differences in these measures between TB-infected 
and uninfected patients were smaller in males than females. This may result in factors other 
than TB status being responsible for similar reductions in FM and FFM in the groups. Viral 
load and CD4 count have been shown to be independent predictors of body composition 
measures (47) 
The effect of gender on body composition measures is well recognised. Studies have shown 
that females have higher amounts of FM and lower amounts of FFM than males (40). In our 
analysis, we found that males had lower FM by 9kg compared to females and their FFM was 
4.85kg higher in multiple regression GEE analysis. This is consistent with other studies 
among HIV-infected adults that have reached the same conclusion. A study by McDermott et 
al compared body composition, as measured by dual-energy X-ray absorptiometry, in 203 HIV-
infected males and 62 HIV-infected females on ART. It found that amount and distribution of FM 
was higher among HIV-infected females than males receiving ART (21). The study suggested 
that females on ART tend to gain more FM than their male counterparts because of hormonal 
differences between the two genders. In their paper on body composition among TB-infected 
patients with and without HIV, Mupere et al found that gender and not HIV status was 
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associated with body composition changes in patients with TB (36). Females had significantly 
higher FM whilst males had higher FFM. This is consistent with our results where females had 
higher FM than males throughout the study period and males has a higher FFM 
 
In the current study, among HIV-infected patients initiating ART and followed up for 12 
months, sex, age, education, smoking, and baseline viral load and CD4 count were associated 
with different body composition measures. TB however showed no association with any of 
the body composition measures over the period. Our results show a large influence of gender 
on the wasting process in HIV-infected individuals more than TB.   
4.2.1 Phase angle 
 
We found no statistically significant association between TB and phase angle, although the 
decrease appeared more pronounced in patients without TB in the profile plot. This is 
consistent with our comparison of percentage changes. Females had lower average phase 
angle than males after adjusting for other possible confounders.  There were no significant 
differences in phase angle between those with TB and those without TB, even after 
stratification by gender. 
In our study the mean phase angle in the population was higher than the mean reported by 
Shah et al in their study of 163 HIV-infected females and 199 HIV-uninfected males. They 
reported a mean (standard deviation) of 5.42 (+/-1.05) and 5.76 (+/-0.93), respectively (15) 
while we found a mean (standard deviation) of 6.6 (+/-2.28) for males and 6.0 (+/-2.86) in 
females. In Uganda, the same author found that co-infection with pulmonary TB and HIV is 
associated with lower phase angle (15).  Among HIV-infected individuals, there was an 
inverse relationship between phase angle and risk of death (2, 59). Schwenk et al in their 
study on Phase angle as a predictor of clinical progression and survival found phase angle 
was independently associated with these factors (2). A study conducted to investigate the 
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prognostic relevance of phase angle measured by BIA among 75 HIV-infected patients found 
that body composition as reflected by phase angle is a determinant of long time survival. 
Sanchez et al, in their study investigating changes in body composition among 24 participants 
with TB found that phase angle increased significantly during TB therapy (59). This is 
contrary to results from our study that showed a decrease in phase angle over the follow up 
period.  
Between baseline and 6 months the phase angle decreased by 4% (-16.2%-7.04%) in TB-ve 
and 2% (-21.8%-8.5%) TB+ve.  
 
 
4.2.2 Fat mass 
 
A comparison of fat mass between those with TB and those without TB showed that HIV-TB 
co-infected had significantly lower fat mass than patients with HIV only. This is line with 
studies that show that HIV/TB co-infection is associated with loss in FM (58). When 
stratified by gender, the difference in FM between those with TB and those without TB was 
significant in females. This difference was however not seen in males. This is consistent with 
results from a study that showed that weight loss in HIV was associated with loss of FM in 
female patients and with loss of FFM in male patients (16). Infection with TB is likely to 
exacerbate FM loss and the difference is more pronounced in females. This might be the 
reason FM differences by TB-infection are more apparent in females and not in males. 
HIV/TB co-infected patients have a lower FM than patients infected with HIV alone and 
HIV-uninfected patients (15, 47). This could mean that at baseline the effect of TB is to lower 
body fat. 
A cross sectional study looking at predictors of body composition among TB patients in 
Mwanza found that TB was associated with a lower FM among HIV-uninfected patients but 
not among HIV-infected patients (40). The authors suggested that the association was not 
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seen in HIV-infected patients because other factors like opportunistic infections could explain 
the deficits in fat mass amongst HIV-infected patients. These results contradict the findings 
of our baseline analysis which suggest that TB may have an enhanced effect on FM of 
patients already infected with HIV. The effect of TB on FM persists in HIV-infected 
individuals in our study. We however observed a difference in HIV-infected females and not 
in males. Our suggestion is that females had generally higher CD4 counts and lower viral 
loads when compared to males. Females were immunologically better off than their female 
counterparts. Other factors i.e. other opportunistic infections or advanced HIV disease may 
be responsible for body composition measures in males and therefore no difference between 
TB-infected and those without TB in this group. 
Although not statistically significant, TB co-infected patients had higher percentage increase 
in FM than TB-uninfected patients. A possible reason is the patients are worse off and taking 
drugs for both conditions; this may lead to a more drastic improvement than their healthier 
counterparts. 
There was an increase in population FM over the three visits. The profile plot shows an 
upwards trajectory and at univariate analysis in GEE there was a 2.248kg increase in FM for 
each visit and this was maintained in multiple regression analysis. An increase in FM over the 
follow up period is consistent with results that patients on ART and on ATT treatment should 
experience an increase in FM. This represents an increase in nutritional status associated with 
improved outcomes.  
Over 12 months, using GEE we determined that TB has no statistically significant effect on 
average FM. Gender however showed an association with FM. Females had significantly 
more FM than males and those with a higher education had significantly more FM than their 
less educated counterparts 
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4.2.3 Body mass index 
 
Our results showed that there was an association between BMI and TB-infection in HIV- 
infected individuals. Although the difference in BMI between those with HIV/TB co-
infection and HIV alone was statistically significant, it was not clinically significant. Both 
groups had a median BMI within normal range. Studies on HIV-infection and BMI have 
shown that HIV without treatment results in body wasting (45, 60).  
Recent studies in Sub-Saharan African countries have shown that levels of obesity seem to be 
increasing (61, 62).The proportion of people with BMI <18.5kg/m
2
 at baseline in the present 
study is less than 7%. This proportion was not statistically significantly different between 
those with TB and those without TB, although those with TB had a higher proportion of 
underweight participants.  The median BMI was 23.5kg/m
2
 and 22.39kg/m
2
 for those without 
TB and those with TB, respectively, indicating that the study population was primarily 
comprised of people of normal weight according to WHO guidelines for BMI classification. 
A substantial number within our population had BMI above 25kg/m
2
 which WHO classifies 
as overweight. Most studies amongst HIV-infected individuals have found the populations to 
comprise of larger numbers below 18.5kg/m
2
.Swaminathan et al compared nutritional status 
in HIV-infected patients with TB and without TB. They found approximately 33% of the 
HIV-infected/TB-uninfected and 50% of HIV-infected/TB-infected had BMI<18.5 (16). This 
was clear evidence of the negative impact of TB and HIV on nutrition. This was not evident 
in our population. We did not find such large differences between those with TB and those 
without. 
The GEE model showed that there was an increase in BMI over the follow up period. This 
was an expected change as all the participants were initiated on ART. A study of patients on 
ART in Nigeria found that patients gained weight during follow-up. There were no 
significant effects of age, sex, viral load or educational status on BMI change in this 
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population (63). The present study showed employment and gender were significantly 
associated with BMI. We suggest that patients who are employed may have a better socio-
economic status and therefore be able to afford better nutrition. There was no association 
between TB and BMI over the follow up period.  
4.2.4 Fat free mass 
 
Although FFM appears lower in TB infected individuals, this difference was not statistically 
significant. There were also no significant differences in FFM after stratification by gender.  
Shah et al in their study compared nutritional status between HIV-infected and HIV-
uninfected individuals with TB and found similar results to ours. They found that  among 261 
HIV-infected patients and 278 HIV-uninfected patients in Sub-Saharan Africa, HIV/TB co-
infection was not associated with lower FFM but with smaller body cell mass.  
Using the GEE model after adjusting for other variables, there was a decrease in FFM over 
the follow-up period.  This could be seen as worrying as FFM has been seen to be associated 
with poor outcomes in HIV-infected individuals. In their study on the effect of ART on body 
composition measures, McDermott et al reported that  patients on ART may experience 
increases in FFM (47) but a study by Silvia et al showed increases in BMI and not FFM with 
use of ART and weight gain in that study was due to changes in FM and not FFM (64). A 
study by Paton et al looked into impact of TB on body composition in HIV-infected males 
and found a mean FFM of 47.7 +/- 5.2 and 45.5 +/- 5.3 in HIV-infected patients without TB 
and with TB respectively. Although those with TB had lower FFM in their study, the 
difference was not statistically significant (6). This is similar to our result where those with 
TB have lower FFM but the difference is not statistically significant. In our analysis of 
factors associated with FFM, we identified sex, age and viral load as predictors of lower 
FFM. No association was found between TB and FFM after adjusting for possible 
confounders in our model. 
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4.2.5 Total body water 
 
Although not statistically significant, baseline TBW was higher for TB+ve patients (33.20kg) 
compared to TB-ve patients (32.00kg) p-value=0.459. There is a decrease in TBW between 
baseline, 6 months and 12 months for both TB+ve and the TB-ve groups and no statistical 
significance in these differences. After adjusting for confounders in GEE analysis there was 
an overall decrease in average TBW (-0.728, p-value=0.004). After one year the median 
TBW was similar in the TB+ve and the TB-ve patients. GEE analysis showed that for every 
increase in log viral load and females had a lower viral load than males. (-8.611; p-value 
<0.001).  These results are similar to results from a study by Ott et al showed an increase in 
TBW with a decrease in FFM in the early stages of HIV infection (46). As the extent of 
malnutrition increases, so does the proportion of TBW as well as depletion of FFM. The 
increase in water results in Oedema in those affected. A general decrease in TBW our 
patients could be indicative of increasing nutritional status due to ART and anti TB treatment. 
It is synonymous with the increase in FM and FFM. 
4.3 Limitations of study 
 
The primary study was conducted at one out-patient HIV treatment facility based within a 
public-sector hospital in South Africa so it is possible that experience differs at other primary 
healthcare facilities and the results may not be generalizable to other facilities.  
 
Sample size was calculated for a different outcome measure and the study was not powered 
to assess the association between TB co-infection and body composition measures. There was 
a substantial amount of missing data. Over the follow up periods some patients have missing 
outcome data.. GEE on the complete case analysis assumed missing data in the main study 
was missing completely at random. This assumption is hardly ever met. Inferences made 
from complete case analysis may be wrong for the entire population if missingness 
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 is not completely at random (MNAR). An attempt to resolve this problem was through 
multiple imputations of the missing data. The data missing was however on the outcome and 
literature on imputation of outcomes varies (65-67). Some authors have argued that multiple 
imputation can be suited for sensitivity analysis although complete case analysis should be 
the analysis of choice more often (66, 67). There has also been some argument that 
imputation might yield biased or incorrect estimates (65). Imputation is only useful if the 
imputed model is correct. The coefficients obtained from the missing data were different for 
some of the variables to those from those obtained from complete case analysis although 
there were some with similar results. More work is needed to confirm which of the 
coefficients obtained are correct. We present complete case results as the main results in this 
paper.  
GEE modelling provides population averaged estimates and these are useful to an extent but 
cannot be used for subject specific inferences. Generalised linear mixed models could be used 
as the next step in analysis to make inferences that are not for the whole population. 
Information on severity of TB and treatment of TB could be useful in finding the relationship 
between TB and nutritional status. We did not have information on severity of TB or linkage 
to care for those with TB in our analysis. These could be confounders in the relationship 
between TB and nutritional status.  
.  
As the sample size was small in the complete case analysis, it was difficult to assess 
interactions between sex and TB. Data on smoking did not take into consideration the amount 
smoked per day. As such, the information is an over generalisation of smoking as it was not 
collected for the purposes of this study.  
Another limitation of the small sample size in our study is that it would have reduced our 
chances of detecting the true effect and the precision of the estimates. This may be the reason 
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that we have some clinically significant differences and results in our analysis that failed to 
reach statistical significance.  
There is indication that there were changes in ART regimens amongst some participants in 
the study. This study did not access the reasons for switching regimens and so we cannot 
determine whether the patient switched due to virologic failure, toxicity, side effects or some 
other reason. This may be the explanation for the decreased nutritional status with regards to 
some of the body composition measures like FFM and phase angle. Patients may not have 
been responding to treatment as anticipated. There is need to investigate treatment failure and 
nutritional status. There is also a need to investigate effects of different ART strategies, both 
Non-Nucleoside Reverse Transcriptase inhibitors (NNRTI) –based and Protease Inhibitor 
(PI) –based on body composition against those who have not initiated ART. This might give 
a better understanding of the role ART plays in the dynamics of HIV/AIDS, TB and nutrition 
in the era of ART.  Further analysis looking at severity of TB is also needed. 
.
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CHAPTER5: CONCLUSIONS&RECOMMENDATIONS 
5.0 Introduction 
 
The conclusions and recommendations in this chapter are drawn from the discussion in the 
preceding chapter. The chapter gives recommendations for future research in this area of 
study. 
5.1 Conclusions 
 
Currently, efforts towards integration of HIV, TB and nutrition care are underway. 
Understanding determinants of body composition measures at baseline and during treatment 
with ART as well as TB treatment may help in the design of interventions that are targeted 
and can improve treatment outcomes. Such determinants include CD4 count, viral load, and 
socio-economic status as well as lifestyle factors like smoking. 
In the current study, patients with HIV/TB co-infection had lower body composition 
measures than participants with HIV only at baseline. They also presented with a lower 
median CD4 count at baseline indicating increased severity of HIV-infection amongst 
patients with TB. This highlights the importance of contact tracing of TB cases to find other 
TB-infected people at early stages of infection. It is important that patients infected with TB 
and HIV be identified so that their health and nutritional status can be monitored. 
Differences in body composition at baseline stratified by gender showed the effect of TB on 
both nutritional measures and immunological measures. The differences in females are more 
apparent as the group of patients is more heterogeneous with regards to severity of HIV- 
infection. Males generally had more severe HIV-infection as determined by CD4 count and 
viral load at baseline whether they had TB or not. These results show that males generally 
present at baseline when they are sicker than females and therefore have generally poorer 
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nutritional status at presentation. Efforts need to be made to identify HIV-infected men early 
for better treatment outcomes.  
Although not statistically significant, results on changes from baseline to 6 months and from 
baseline to 12 months show that TB+ve have larger increases in both nutritional and 
immunological measures than TB-ve patients. This shows that patients respond really well to 
treatment and improvement after treatment commencement is marked.  Treatment of these 
conditions is therefore of great importance as there seems to be substantial improvements in 
this group once treatment is started.  
In all analyses using GEE, TB was not significantly associated with any of the body 
composition measures modelled. This could be suggestive that over the course of treatment, 
identifying people in need of nutritional supplementation should be based on a host of factors 
and body composition measures, not just TB. TB may not be the main and only driver of 
nutritional indicators in HIV-infected individuals. 
More than 50% of participants had normal BMI and less than 7% had BMI <18.5kg/m
2
. This 
indicates that this group of patients was not severely malnourished. As much as 14.41% of 
the participants had BMI above 30kg/m
2
.The relationship between obesity, malnutrition and 
HIV need to be investigated. The face of HIV is changing with regards to nutrition. The 
marker for infection is no longer severely malnourished patients. Patients indicated for 
treatment with CD4 count below 350cells/mm
3
 may actually be obese.  
It is of great importance to study medication adherence, medical complications and drug 
regimens for both HIV and TB to further understand how these have an effect on body 
composition. Assessment of nutrition by BIA in HIV-infected individuals needs to be a part 
of diagnosis and therapy regardless of TB status. 
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5.2 Recommendations 
 
Nutritional supplements  
Measurement of nutritional status is very important amongst HIV-infected individuals 
regardless of TB status. At baseline, differences in body composition by TB status were 
more apparent in females but males presented with lower body composition measures 
regardless of TB status.  Targeted nutritional interventions according to TB might only 
make sense for females. Males however should all receive nutritional intervention 
regardless of TB status. On average males present with poor nutritional and 
immunological indicators. Our recommendation is that the decision to give and maintain 
nutritional supplementation be made per individual after careful consideration of all 
other factors that could be associated with body composition and assessment of their 
nutritional status. 
Identification of HIV-infected individuals and TB preventative therapy 
Comparison of the two groups at baseline showed that HIV-infected patients with TB 
present with lower body composition measures compared to HIV-infected individuals 
without TB. This is evidence that TB in HIV exacerbates the malnutrition from HIV on 
its own. Identification of HIV-infected individuals early and getting them on treatment to 
reduce risk of acquiring TB is important. Use of TB preventative therapy for HIV-
infected individuals could also be helpful.  
Monitoring of nutritional status over treatment period 
The study found that although changes of BMI and FFM over time were consistent with 
improved nutrition, phase angle, which has been shown to be a predictor of survival in 
chronic disease management, decreased with time. FFM also showed reduction over the 
study period. Over the period of 12 months the group did not show definite increases in 
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nutritional status. Thus, consistent monitoring after ART initiation of nutritional status is 
important in all HIV-infected individuals. 
Predictors of body composition measures 
Baseline CD4 and viral load were found to be important predictors of BMI, FFM and 
TBW. Education and employment were also found to be associated with measures of 
nutrition. Early diagnosis and treatment is therefore of importance in the nutritional 
status of HIV-infected individuals. Socio-economic status is an important predictor of 
nutritional status and could be used to determine those most in need of interventions.  
Adherence and treatment failure 
Although over time our study showed an increase in BMI and FM it also showed a 
decrease in phase angle and FFM on the entire group from baseline throughout the study. 
These are important predictors of treatment success in patients. It is important to 
investigate the response to treatment for different body composition measures. Patients 
on ART and TB treatment must be closely monitored to see if these decreases are a result 
of non-adherence, treatment failure due to medication resistance, or side effects of ART. 
    Longitudinal data data 
Missing data is a major problem when it comes to analysis of missing data. It is 
important to ensure that there is minimal loss to follow up during longitudinal data data 
collection. Analysis using incomplete data is difficult and might not yield results that can 
be generalised to the entire population. Multiple imputation is one way of dealing with 
the problem of missing data. However it has its own pitfalls and may not yield accurate 
estimates (66). As part of our analysis we did a sensitivity analysis using multiple 
analyses to compare with the results obtained from our complete case analysis. It is 
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important to use explore different statistical methods to analyse datasets with missing 
data.  
5.3 Potential areas for research 
 
It is important to note that the information obtained in this study may not be generalizable to 
different populations. The amount of missing data makes it difficult to generalise. A more 
rigorous look at the effect of TB taking into account the severity, type and treatment of TB is 
important. This study lays the groundwork for future longitudinal data studies in different 
populations to study trends in nutritional status. 
 
 
 
 
 
 
 
 
 
 
 
Student number: 740746 
 
75 
 
References 
1. UNAIDS (2012) Report on the global AIDS epidemic 2012.  
 
2. Schwenk A, Beisenherz A, Romer K, Kramer G, Salzberger B, Elia M. Phase angle from 
bioelectricalimpedence analysis remains an independent predictive marker in HIV-
infectected patients in the error of highly active antiretoviral treatment. Am J Clin Nutr. 
2000;72:496-501. 
 
3. Macallan D. Wasting in HIV infection and AIDS. Journal of Nutrition. 1999;129:238S-
42S. 
 
4. Liu E, Spiegelman D, Semu H, Hawkins C, Guerino C. Nutritional Status and Mortality 
Among HIV-Infected Patients Receiving Antiretroviral Therapy in Tanzania. Journal of 
infectious disease. 2011;204(2):282-90. 
 
5. WHO.Technical Consultation on Nutrient Requirements for People Living with 
HIV/AIDS. 2003. Geneva Switzerland: World Health Organisation.  
 
6. Paton NI, Castello-Branco LR, Jennings G. Impact of tuberculosis on the body 
composition of HIV-infected men in Brazil. J Acquir Immune Defic Syndr Hum 
Retrovirol. 1999;20:265-71. 
 
7. WHO. Global tuberculosis control: surveillance, planning, financial. 2005;Geneva 
Switzerland:World Health Organisation. 
 
8. Mukadi YD, Maher D. Tuberculosis case fatality rates in high HIV prevalence populations 
in sub-Saharan Africa. . AIDS. 2001;15(2):143-52. 
 
9. Gillespie S, Suneetha K. HIV/AIDS and Food and nutrition security : From Evidence to 
Action. 2005. 
 
10.Kotler DP, Wang J, Pierson RN. Body composition studies in patients with acquired 
immune  syndrome. Am J Clin Nutr. 1985;1985(42):1255-65. 
 
11. Kotler DP, Tierney AR, Wang J, Pierson RN. Magnitude of body cell mass depletion and 
the timing of death from wasting in AIDS. Am J Clin Nutr. 1989;50:444-7. 
 
12. Chlebowski RT, Grosvenor MB, Barnhard NH, Morales LS, BulcavageLM. Nutritional 
status, gastrointestinal dysfunction, and survival in patients with AIDS. Am J 
Gastroenterol. 1989;84:1288-93. 
 
13. Lucas SB, De Cock KM, Hounnou A, Peacock C, Diomande M, Honde M. Contribution 
of tuberculosis to slim disease in Africa. British Medical Journal. 1994;308(6943):1531-
3. 
 
14. Van Lettow M, Fawzi WW. Triple trouble: the role of malnutrition in tuberculosis and 
human immunodeficiency virus co-infection. Nutr Rev. 2003;61(3):81-90. 
 
Student number: 740746 
 
76 
 
15. Shah S, Whalen C, Kotler D, Mayanja H, Namale A, Melikian G, et al. Severity of 
Human Immunodeficiency Virus Infection Is Associated with Decreased Phase Angle, 
Fat Mass and Body Cell Mass in Adults with Pulmonary Tuberculosis Infection in 
Uganda. The journal of nutrition. 2001;131(11):2843-7. 
 
16. Swaminathan S, Padmapriyadarsini C, Sukumar B, IIiayas S. Nutritional status of persons 
with HIV infection , persons with HIV infection and Tuberculosis, and HIV-negative 
individuals from Southern India. Clinical Infectious Diseases. 200;46:946-9. 
 
17. WHO. Nutrient requirements for people living with HIV/AIDS. WHO report. 2003:1-31. 
 
18.Evans D, McNamara L, Maskew M, van Amsterdam D, Baines N, Webster T, et al. 
Impact of nutritional supplementation on immune response, body mass index and 
bioelectrical impedance in HIV-positive patients starting antiretroviral therapy. Nutrition 
Journal. 2013;12(111): . 
 
19. Villamor E, Saathoff E, Mugusi F, RJ B, Urassaand W, Fawzi WW. Wasting and body 
composition of adults with pulmonary tuberculosis in relation to HIV-1 coinfection, 
socioeconomic status, and severity of tuberculosis. European Journal of Clinical 
Nutrition 2006;60:163-71. 
 
20. Zachariah R, Spielmann MP, Harries AD, Salaniponi FML. Moderate to severe 
malnutrition in patients with tuberculosis is a risk factor associated with early death. 
Transactions of the Royal Society of Tropical Medicine and Hygiene. 2002;96:291–4. 
21. McDermott AY, Shevitz A, Knox T, Roubenoff R, Kehayias J, Gorbach S. Effect of 
highly active antiretroviral therapy on fat, lean, and bone mass in HIV-seropositive men 
and women. Am J Clin Nutr. 2001;74:679-86. 
 
22. Dehghan M, Merchan AT. Is bioelectrical impedance accurate for use in large 
epidemiological studies? Nutrition Journal 2008;7(26). 
 
23. Semba RD, Darnton-Hill I, de Pee S. Addressing tuberculosis in the context of 
malnutrition and HIV coinfection. Food Nutr Bull 2010; 31:S345–S64. 
 
24.  Macallan DC. Malnutrition in tuberculosis. Diagn Microbiol Infect Dis. 1999;34(2):153–
7 
 
25. Department of Health Republic of South Africa. South African National Guidelines on 
Nutrition for people living with HIV, AIDS, TB and other Chronic Debilitating 
Conditions. 2007. 
 
26.  Mutimura E, Anastos K, Lin Z, Cohen M, Binagwaho A, Kotler DP. Effect of HIV 
Infection on Body Composition and Fat Distribution in Rwandan Women. Journal of the 
International Association of Physicians in AIDS Care. 2010;9(3):173-8. 
 
27. Maiaa BS, Engelsonb ES, Kotlerb DP. Antiretroviral therapy affects the composition of 
weight loss in HIV infection: Implications for clinical nutrition. Clinical 
Nutrition2005;24:971-8. 
Student number: 740746 
 
77 
 
28. Van Lettow M, Harries AD, Kumwenda JJ, Zijlstra EE, Clark TD, Taha TE, et al. 
Micronutrient malnutrition and wasting in adults with pulmonary tuberculosis with and 
without HIV co-infection in Malawi. BMC Infectious Diseases 2004;4(61):1-8. 
29. Paton NI, Ng Y. Body composition studies in patients associated with tuberculosis 
Nutrition. 2006;22:245-51. 
 
30. Knox TA, Sanders MZ, Fields-Gardner C, Moen K, Johansen D, Paton NI. Assessment of 
Nutritional Status, Body Composition, and Human Immunodeficiency Virus–Associated 
Morphologic Changes. clinical infectious diseases. 2003;36(supp2):s63-8. 
 
31. Suttmann U, Ockenga J, Selberg O, Hoogestraat L, Deicher H. Incidence and prognostic 
value of malnutrition and wasting in human immunodeficiency virus-infected 
outpatients. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8:239-46. 
 
32. Tang AM, Forrester J, Spiegelman D, Knox TA, Tchetgen E. Weight loss and survival in 
HIV-positive patients in the era of highly active antiretroviral therapy. J Acquir Immune 
Defic Syndr 2002;31:230-6. 
 
33. Kotller DP, Wang J, Pierson RN. Body composition studies in patients with the aquired 
immunodeficiency syndrome. Am J Clin Nutr. 1985;57:15-9. 
 
34. Mutimura E, Anastos K, Lin Z, Macallan DC. Effect of HIV infection on body 
composition and fat distribution in Rwandan Women. Journal of the international 
Association of physicians in AIDS care 2010;9(3):173-8. 
 
35. Harries A, Nkhoma WA, Thompson P, Nyangulu DS, Wirima J. Nutritional status in 
Malawian patients with pulmonary tuberculosis and response to chemotherapy. European 
Journal of Clinical Nutrition. 1988;42:445-50. 
 
36. Mupere E, Zalwango S, Chiunda A, Okwera A, Mugerwa R, Whalen C. Body 
Composition among HIV-seropositive and HIV-seronegative Adult Patients with 
Pulmonary Tuberculosis in Uganda. Ann Epidemiol 2010;20(3):210-6. 
 
37. Corbett EL, Marston B, Churchyard GJ, De Cock KM. Tuberculosis in sub-Saharan 
Africa: opportunities, challenges, and change in the era of antiretroviral treatment. 
Lancet. 2006;367(9514):926-37. 
 
38. Visnegarwala F, Raghavan SS, Mullin CM, Bartsch G, Wang J, Kotler D, Gibert CL, 
Shlay J, Grunfeld C, Carr A, El-Sadr W.Sex differences in the associations of HIV 
disease characteristics and body composition in antiretroviral naive persons. Am J Clin 
Nutr. 2005;82:850-6. 
 
39. Range NS, Malenganisho W, Temu MM. Body composition of HIV positive patients with 
tuberculosis: a cross sectional study in Mwanza, Tanzania. Annals of Tropical Medicine 
and Parasitology. 2010;104(1):81-90. 
 
40. PrayGod G, Range N, Faurholt-Jepsen D, Jeremiah K. Sex, Smoking, and Socio-
Economic Status Are Associated with Body Composition among Tuberculosis Patients in 
a Deuterium Dilution Cross-Sectional Study in Mwanza, Tanzania. The Journal of 
Nutrition. 2013. 
Student number: 740746 
 
78 
 
41. Swanson B, Keithley K. Bioelectrical impedance analysis (BIA) in HIV infection: 
principles and clinical applications. The journal of the association of nurses in AIDS 
care. 1998;9(1):49-54. 
 
42. Barbosa-Silva MCG, Barros AJ, Wang J, Heymsfield SB, . PR. Bioelectrical impedance 
analysis: population reference values for phase angle by age and sex. Am J Clin Nutr. 
2005;82(1):49-52. 
 
43. Kyle UG, Genton L, Slosman DO, Pichard C. Fat-Free and Fat Mass Percentiles in 5225 
Healthy Subjects Aged 15 to 98 Years. Nutrition. 2001;17:534-42. 
 
44. WHO. Physical status: the use and interpretation of anthropometry. Report of a WHO 
Expert Committee Geneva: WHO. 1995. 
 
45. Benova L, Feilding K, Greig J, Nyang'wa BT, Casac EC. Association of BMI category 
change with change TB treatment mortality in HIV positive smear negative and 
Extrapulmonary TB patients in Myanmar and Zimbabwe. Plosone. 2012;7(4):e35948. 
 
46. Ott M, Fischer H, H P. Bioelectrical impedence analysis predicts as a predictor of 
survival in patients with human immunodeficiency virus infection. J Acquir Immune 
Defic Syndr Hum Retrovirol. 1995;9:20-5. 
 
47. McDermott A, Shevitz A, Knox  T, Roubenoff R, Kehayias J, Gorbach S, et al. Effect of 
highly active antiretroviral therapy on fat, lean, and bone mass in HIV-seropositive men 
and women. Am J Clin Nutr. 2001;74:679-86. 
 
48. Fox M, Maskew M, MacPhail A, Long L, Brennan A, Westreich D, et al. Cohort profile: 
The Themba Lethu Clinical Cohort, Johannesburg, South Africa. Int J Epidemiol 2013. 
2013;42:430-9. 
 
49. National Department of Health RoSA. Clinical Guidelines for the Management of HIV & 
AIDS in Adults and Adolescents. South African Department of Health. 2010. 
 
50. Schwenk A, Beisenher A, Kremer G, Dieh V, Salzberger B, Fätkenheuer G. Bioelectrical 
impedance analysis in HIV-infected patients treated with triple antiretroviral treatment. 
Am J Clin Nutr. 1999;70:867-73. 
 
51. Kyle UG, Schutz Y, Dupertuis YM, Pichard C. Body composition interpretation. 
Contributions of the fat-free mass index and the body fat mass index. Nutrition. 
2003;19(7):597 - 604. 
 
52. Klauke S, Fischer H, Rieger A, Fruhauf L, Helm EB. Use of bioelectrical impedance 
analysis to determine body composition changes in HIV-associated wasting. 
International journal of  STD & AIDS. 2006;16(4):307-13. 
 
53. Song J, Huiman X, Lyles RH. A GEE Approach for Estimating Correlation Coefficients 
Involving Left-censored Variables. Journal of Data Science. 2004;2:245-57. 
 
54. Vajpayee M, Kanswal S, Seth P, Wig N. Tuberculosis infections in HIV-infected Indian 
Patients. AIDS Patient Care STDS. 2004;18:209 - 13. 
Student number: 740746 
 
79 
 
55. Martin DJ, Sim JG, Sole GJ, Rymer L, Shalekoff S. CD4+ lymphocyte count in African 
patients co-infected with HIV and tuberculosis. J Acquir Immune Defic Syndr Hum 
Retrovirol. 1995;8:386 - 91. 
 
56. Alvarez-Uria G, Midde M, Pakam R, Kannan S , Bachu L, Paton NI. Factors Associated 
with Late Presentation of HIV and Estimation of Antiretroviral Treatment Need 
according to CD4 Lymphocyte Count in a Resource-Limited Setting: Data from an HIV 
Cohort Study in India. Interdisciplinary Perspectives on Infectious Diseases. 
2012;2012(2012). 
 
57. Wanchu A, Kuttiatt VS, Sharma A, Singh S, Varma S. CD4 cell count recovery in 
HIV/TB co-infected patients versus TB uninfected HIV patients. Indian J Pathol 
Microbiol. 2010;53(4):745 - 9. 
 
58. Mupere E, Malone L, Zalwango S, Okwera A, Nsereko M, Tisch DJ, et al. Wasting 
among uganda men with pulmonary TB is associated with linear regain in lean tissue 
mass during and after treatment in contrast to women with wasting who regain fat tossue 
mass:prospective cohort study. BMC Infectious Diseases. 2014;14(24):1471-81. 
 
59. Sanchez A, Azen C, Jones B, Louie S, Sattler F. Relationship of Acute Phase Reactants 
and Fat Accumulation during Treatment for Tuberculosis. Tuberculosis Research and 
Treatment. 2011;2011(2011). 
 
60. Macallan DC, Noble C, Baldwin C, Foskette M. Prospective analysis of patterns of 
weight change in stage IV human immunodeficiency virus infection1 Am J Clin Nutr. 
1993;58(3):417-24. 
 
61. Hendricks KM, Mwamburi DM, Newby PK, Wanke CA. Dietary patterns and health and 
nutrition outcomes in men living with HIV infection. Am J Clin Nutr 2008;88:1584-92. 
 
62. Jayne J, Scrimgeour AG, Polhemus ME, Otieno L, Bovill ME. Dietary and Socio-
Economic Correlates of Nutritional Status in a Rural Adult Kenyan Population. African 
Journal of Food, Agriculture, Nutrition and Development. 2011;11(4):1684-8. 
 
63. Denue BA, Ikunaiye PNY, Denue CBA. Body mass index changes during highly active 
antiretroviral therapy in Nigeria. Eastern Mediterranean Health Journal. 2013;19(3):89-
97. 
 
64. Silva M, Skolnik PR, Gorbach SL. The effect of protease inhibitors on weight and body 
composition in HIV-infected patients. AIDS 1988;12:1645-51. 
 
65. Altman DG. Missing outcomes in randomised trials: addressing the dilema. . Open Med 
2009;3(2):e51-e3. 
 
66. Higgins JP, White IR, AM. W. Imputation methods for missing outcome data in meta-
analysis of clinical trials. Clin Trials 2008;5(3):225-39. 
 
67. Groenwold RH, Donders RT, Roes KC, Harrel FE, KG. M. Dealing with missing 
outcome data in randomized trials and observational studies Am J Epidemiol. 
2012;175(3):210-7.
Student number: 740746 
 
80 
 
 
 
 
Student number: 740746 
 
81 
 
 
 
 
 
 
Student number: 740746 
 
82 
 
 
